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ABSTRACT
Megakaryopoiesis occurs within the bone marrow microenviroement under the
interactive influence of stomal cells, growth factors and extracellular matrix (ECM)
on hematopoietic stem cells. The mechanisms regulating megakaryopoiesis are
currently not well studied. The extraceltula¡ matrix components stimulate stromal 
and
hematopoietic cell proliferation, localise progenitor cells regionally and effect
hematopoietic differentiation. An important component of ECM is fibronectin 
whose
ligands are the pl integrins. The integrins a¡e not signal tansducers but likely
transduce signals internalty via the associated tetraspan molecules'
This study demonstrated that both fibronectin and stromal cells increased and
maintained CD34+ ce[s in cultr¡re. Both increased the differentiation of
megakaryocyte precursors as indicated by the increase in expression of cD61 and
cD41a, and cFU-MKs. The role of integrins cD49d and cD49e, with their
associated tetraspan molecules CD63 and the recentþ described CDlsl' in
megakaryopoiesis activated by fibronectin and stromal cells was then studied' Using
immunofluorescence flow cytometry, the majority (g4.5%) of CD34* cells expressed
cD4gd,whereas a minority (5.4yù expressed cD49e. With the exception of 
tetraspan
cD63, which was positiv e 27Yo on cD34+ cells, the other tetraspan molecules 
(cD9,
cD53 and cD15) examined were positive in less tl:fjn 6% of cD34* cells'
Fibronectin produced an initiat fall in CD49d expression which subsequently
increased with continued culture, whereas fibronectin increased CD49e expression
from the initiation of culture. Preliminary experiments showed that fibronectin led 
to
an increase in tetaspans cD63 and cDl51. These were for¡nd to be co-expressed
with cD4gd and cD4ge on cD34* and cD34- cells. The physical association of
CD63 and CD151 was confirmed by immnnoprecipitation. Together, these data
suggest that interaction of fibronectin with the integrins upregulated their signal
fiansduction molecules. Correlating these changes $'ith the increase in
megakaryocyte progenitor differentiation indicates a role for CD49d and CD49e 
and
associated tetaspans in megakaryopoiesis which was induced by fibronectin'
The role of these molecules in megakaryopoiesis was further confirmed in a mouse
stromal cell culture model. Antibodies to cD49d and cD49e as well as to cDl5l
D(
inhibited stromal cell induced megakaryopoiesis as monitored by CD61 and CD41a
expression and CFU-MK rissay.
cD151 was shown to be physically associated with cD6l by immunoprecipiøtion' It
is important in platelet-platelet interaction as an agonist antibody to CDl5l-induced
platelet aggregation. The data indicate that cDl5l associated with cD61 early in
megakaryocyte development. Inhibition of the function of cD15l led to decrease in
megakaryocytic differentiation hightighting its role in megakaryopoiesis as a signal
transducer for the integrins CD49d and CD49e'
This study had shed new light on the factor involved in the complex process of
megakaryopoiesis.







A major focus in the field of haematology continues to be the identification of the early
haematopoietic stem cell (HSC). These may be considered as a set of immature cells
located after birth in bone manow (BM). In the BM, HSC proliferate and differentiate
within a microenvironment consisting of stromal cells, extracellular matrix (ECM) and
different secreted cytokines, each interacts to direct and coordinate regulation ofblood cell
development. Adhesion molecules involved in the interaction of HSC with sinusoidal
endothelium and stromal cells in BM, may play a cental role in many biological processes.
Cell-cell and cell-extracellular matrix interactions are fundamenøl processes which
regulate the proliferation and differentiation of HSC. These adhesive interactions are
mediated by specific pairs of cell surface receptors and counter receptors (ligands)
including integrin superfamily, immunoglobulin superfamily, p-selectin and cadhesins.
Another important group of molecules is the tetraspans or transmembrane 4 superfamily
(TM4) which have two unequal extracellular domains separated by four transmembrane
domains. These molecules are associated on the cell surface with other partner molecules,
in particular members of the p integrin superfamily. Numerous data suggest a possible
finctional connection between integrins and tetraspan proteins to form an active complex
following integrinJigand interactions (Rubinstein et a1., 1994; Wright et al., 1994; Shaw et
al., 1995). Although a function in the regulation of cell proliferation and activation seem
likely from some datA unlike the other protein superfamilies, the tetraspan superfamily
fi¡nction is not yet clear (Wright et al., 1994).
The wide clinical and research use of the CD34 antigen as a marker of stem and progenitor
cells has contributed to the blanket application of the term "stem cell" to refer to all CD34*
cells in the BM. In fact less then one percent of BM mononuclear cells is CD34*.
Megakaryocytes (MK) are derived from the haematopoietic stem cells. These cells give
rise to platelets which play an important role in haemostasis. Most MK progenitors are
thought to originate in the BM, where they normally comprise between 0.037 and 0.37 of
all ma¡row cells (Golde etaI.,19S5). Little is known about the mechanisms which promote
proliferation and differentiation of HSC to MK.
I
Thisstudy was presented the initial aim of isolating of CD34+ cells from cord blood, which
were further cultured in different culture systems invitro, such as serum free medium alone,
in the presence or absence of fibronectin, stromal cells and specific cytokines to assess the
role of p integrins and tetaspan molecules in megakaryopoiesis. This introduction
comprehensively reviews the process of haematopoiesis, the BM microenvironment, CD34*
cells and adhesion molecules, with tetaspan superfamily relevant to MK proliferation and
differentiation.
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1.2.THE PROCESS OF HAEMATOPOIESIS:
AN O\rERVIEW
I.2.I BONE MARRO}V ANATOMY
The bone marrow, one of the largest organs in the human body, is the principal site for
blood cell formation. In the normal adult its daily production amounts to about 2.5 billion
red cells, 2.5 billion platelets and 2.0 billion granulocytes per kilogram of body weight
(Nathan et a1.,1987).
Bone marrow is an extremely complex tissue and sustained cellular production depends on
the presence of pools of primordial cells and stem cells, capable of both self-replication and
differentiation. The most primitive pool consists of pluripotential stem cells with the
capacity for continuous self-renewal. The more mature pools consist of differentiated
progenitor cells with maturation restricted to single cell type and with no capacity for self-
renewal. The proliferative activity of these pools involves humoral feedback from
peripheral target tissues as well as cell-cell interactions within the microenvironment of the
manow. The microenvironment of the manow cavity (Weiss, 1976; V/olf, 1979) is a vast
network of vascular channels or sinusoids that separate clumps of haematopoietic cells,
including fat cells which are found in the intrasinusoidal spaces. The vascular and
haematopoietic compartrnents are joined by reticular fibroblastoid cells that form the
adventitial surfaces of the vascular sinuses and extend cytoplasmic processes to create a
lattice on which blood cells are for¡nd. The location of the different haematopoietic cells is
not random. FoT example, clumps of megakaryocytes (MK) are found adjacent to marrow
sinuses. They shed platelets, the fragments of their cytoplasm, directly into the lumen.
1.2.2 HAEMATOPOIESIS:ANATOMYAI\DPHYSIOLOGY
Haematopoiesis is the complex process that results in the continuous production of the full
spectrum of erythroid, myeloid and lymphoid cells throughout the lifespan of an organism.
During human development, haematopoiesis originates in the embryonic yolk sac but shifts
to the fetal liver and spleen, and later to the fetal bone marrow (Nathan et al., 1987).
J
The haematopoietic system is rema¡kable not only for its huge quantitative ouþut of cells,
but also for its ability to respond effrcientþ to a variety of physiological stimuli, including
blood loss, tissue injury and immunologic challenge. This system is supported by a
relatively small pool of primitive cells, the pluripotent haematopoietic stem cells, which
have estimated frequency of approximately 2 in 100,000 bone marrow mononuclear cells
(Nathan et al., 1987). This pluripotent stem cell, capable of both self-renewal and
differentiation into all haematopoietic lineages, still forms the basis of current models of
haematopoiesis (Lichnnan et al., 19Sl). Differentiation of the pluripotent stem cell results
in the production of increasingly mature pools of progeny, called haematopoietic progenitor
cells. In the adult the primary site of haematopoiesis is the bone malrow, where
haematopoietic stem and progenitor cells are closely associated wittt stroma a
heterogeneous population of connective and vascula¡ tissue cells, including smooth muscle,
reticular cells, adipocytes, osteoblasts, and vascular endothelial cells (rWeiss, 1976).
I.2.3 PROLIFERATION AND DIFFERENTIATION OF
HAEMATOPOIETIC STEM CELLS
Most haematopoietic stem cells are quiescent in the G6 stage of the cell cycle. A complex
system of events is required by which haematopoietic stem cells begin to proliferate and
either self-renew or commit to generate the large population of mature blood cells
continuously required during life Fig.1.1. However, the most mature progenitor cell
populations cycle more actively and are capable of extensive proliferation and expansion in
response to a number of interacting cytokines, and in bone malrow, where stem cells and
progenitor cells are closely associated with the bone ma¡row microenvironment.
I.2.3.I TIIE CD34 PHENOTYPE OF STEM CELLS
The discovery and characterisation of the gþophosphoprotein cell surface antigen CD34
opened the door to numerous laboratory and clinical therapeutic studies by providing a
basis for phenotypic characterisation, quantitation, and isolation of haematopoietic cells
(Krause et aL.,1996). [CD stands for 'cluster of differentiation' and denoted originally a
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FIG. 1.1 HAEMATOPOIETIC STEM CELLS PROLIFERATION AND
DIFFERENTIATION. (Copy from AMGEN).
cluster of monoclonal antibodies that was found during workshop studies to react similarly
in various tests, ultimately therefore recognising a common cell-surface antigen.]
CD34 is expressed on developmentally early lymphohaematopoietic stem and progenitor
cells (Civin et al., 1984), small-vessel endothelial cells, and embryonic fibroblasts. CD34*
bone marow cells comprise only l.SYo of marrow mononuclear cells, but contain
progenitor cells for all lymphohaematopoietic lineages, ¿ts evidenced by the finding that
CD34* cells purified from m¿uro\¡¡ can reconstitute haematopoiesis of primates, humaJm, or
mice undergoing autologous marrow reinfusion after BM transplantation (Schmitz et al.,
1995). CD34 haematopoietic cells obtained from marow or blood are in clinical use in
transplantation and gene therapy studies, including ongoing attempts to expand
haematopoietic stem/progenitor cells ex vivo. Although CD34 is an important marker of
early haematopoietic stem/progenitor cells in experimental and clinical haematopoiesis, the
function of CD34 is not yet clear. CD34 may have a role in such fundamental processes as
haematopoietic progenitor cell development and inflammation. Recent experiments on the
fr¡nction of CD34 indicate that CD34 expressed on endothelial cells may play a role in
leukocyte adhesion and "homing" during the inflammatory process, and it has been
hypothesised that CD34 plays a role in stem/progenitor cell localisation/adhesion in the
BM. (Civin et a1.,1987).
1.2.3.2 X'REQUENCY AND PHENOTYPE OF CD34* CELLS
CD34 was discovered as the result of a strategy to develop antibodies that specifically
recognise small subsets of human marrow cells but not mature blood or lymphoid cells
(Civin et a1.,1984). In recent years the determination of the number of CD34* cells has
become the standard for the estimation of the number of haematopoietic stem cells.
CD34 antibodies specifically detect an average of only l.5Yo of low-densþ mononuclear
cells from BM aspirates of normal donors (Civin et al.,l9S4). ln contrast, there is less than
0.5o/o CD34 labelling of peripheral blood (PB) cells and approximately 1% of the
mononuclear cells in cord blood (CB) (Civin et al., 1987). The CD34* cell population from
normal human BM is enriched in morphologic blast cells, in contrast to the CD34' cell
fraction, which contains predominantly recognisable precursor cells at diverse maturational
stages of haematopoiesis.
5
The discovery of CD34 as a haematopoietic cells-surface antigen has transformed and
accelerated studies into developmental haematopoiesis. Immunoaffrnity-purifred CD34*
ma¡¡ow and cord blood cells are l0- to 100-fold enriched in colony-forming r:nits (CFUs)
whereas CD34- cells population are depleted in CFUs. The CD34- cells include CFU-
macrophage (CFU-M), CFU-granulocyte (CFU-G), CFU-GM, burst-forming units-erythoid
(BFU-E), and are particularly enriched in the earliest types of colony-forming cells, such as
CFU-mix and CFU-blast (Staauss et al., 1936). A fraction of most mature unipotent CFU,
such as CFU-E and CFU-G, can be found in the CD34-cell fraction. There are two distinct
populations of CD34* BM cells that differ in their relative levels of surface CD34
expression by flow cytometric analysis:
l. The CD34 on# pop.tlation contains the majority of the immature haematopoietic
progenitor cells,
2. The CD34 di' population contains more lineage-committed progenitors as assayed ín
vitro. The CD34 tricht populations enriched for unipotent progenitors, including CFU-GM,
BFU-E, CFU-E, CFU-MK and even more highly enriched for the developmentally early
multþotential CFU-GEMM (CFU-mix), CFU-blast, and long-term culture initiating cells.
The very immatr¡re lymphoid cells are also CD34*. The stage-specific expression of CD34
in both human and mr¡rine haematopoietic stem/progenitor cells suggests a potential
regulatory role for CD34 in the early phase of developmental haematopoiesis.
1.2.3.3 IN WTRO QUAIITITATION OF HAEMOPOIETIC STEM CELLS
Siena and coworker were the first group to describe CD34 measurement by flow cytome@
as a meas¡urement of HSC in mobilised peripheral blood (Siena et a1., 1989). CD34
meas¡urement was found to have obvious advantages over traditional CFU-GM assay, in
particular the result is available the same day instead of 14 days later. Now, flow cytometric
analysis of CD34 immunostained blood or marrow preparations is the standard quahty
control method for harvested BM.
The first in vitro functional assays were the haematopoietic colony assays that evaluate
ability of committed progenitor cells to produce one or more haematopoietic lineages after
culture in permissive conditions (Dexter et a1., 1974). The assays for erythriod and myeloid
6
progenitors require quantification of morphologically distinct colonies 7 to 20 days a.fter
plating in semi-solid media supplemented with cytokines. These include assays for colony
forming unit (CFll)-granulocyte macrophage (CFU-GM), burst-forming units (BFU)- and
CFU-erythiod, CFU-megakaryocytes (MK) and CFU -granulocytelerythrocytel
monocyte/megakaryocyte (GEMM). The long-term culture system assay can detect an even
more primitive progenitor associated with long-term repopulating ability. This cell is
defined by its ability to produce CFU-GM, BFU-E, and CFU-GEMM at 5 week or more
than ten weeks when co-cultured with ma¡row stromal cells in appropriate liquid culture
system (Sutherland et al., 1989).
I.2.4 HAEMATOPOIETIC MICROEI¡-VIROI\MENT
The haematopoietic microenvironment can be categorised into three main areas, the cellular
elements, the haematopoietic cytokines, and the extracellular matrix molecules. The cellular
elements consist of haematopoietic stem cells and progenitor cells that gave rise to mature
blood cells and various types of connective tissue cells that comprise the bone malrow
stroma (fibroblasts, macrophages, endothelial cells and fat cells). The haematopoietic
cytokines consist of a variety of growth factors: stem cell growth factor, macrophage
colony-stimulating factor, various interleukin growth factors and especially megakaryocyte
growth development factor (MGDF). All of these cytokines have been cloned and (for
many) their receptors identified (Migliaccio 1996). The extracellular matrix was long
considered to be a structural scaffolding for many tissues. It is appreciated as a dynamic,
complex structure that plays an important role in the development, adhesion, and migration
of cells. Matrix components stimulate sfomal cell proliferation, augment the regional
localisation of progenitor cells, and effect haematopoietic cells proliferation and
differentiation. Likewise, complex interactions between human cytokines and extracellular
matrix seemingly play a role both in comparbnentalising haematopoietic cytokines and in
presenting complex developmental signals to developing blood cells (Wunder et al., 1994)
Figl.2.
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proliferation and differentiation of normal haematopoietic stem cells (HSC) occurs vvithin
the human bone marrow microenvironmen! which comprises stomal cells 
including
fibroblasts, adipocytes, macrophages, smoottr muscle and endothetial 
cells' The importance
of smomal cells for the proliferation of early haematopoietic cells has been demonstrated
using precursors of colony forming ì¡nit (cFÐ which only proliferate and produce cFC 
in
the presence of stromal cells (Andrews et al., 1939). These stomal cells also influence
haematopoietic cells differentiation. Alterations of culture conditions in 
murine LTBMCs
can deterrrine whether myloid or pre-B cells are produced.(whitlock et 
at'' 1982)'
The development of haematopoietic stem cells itt vivo arld in vitro, demonsEates 
that the
haematopoietic microenvironment of the haematopoietic organs is mediated 
largely by this
phenot¡pically and perhaps functionally diverse population of stromal cells that endow
these organs with the unique capacity to support haematopoiesis (fÞxter et al" 1977;
whitlock et al., lg82). Much effort has been devoted to understanding the 
mechanisms
responsibre for the ability of stromal ce[s to promote the survivar and differentiation 
of
primitive HSC. From most studies it appears that stromal cells from bone marrow 
not only
release a wide variety of cytokines witb a range of biological activities 
on HSC (Alberico et
al., 1987; Donshkind et al., 1990) but also expfess a broad repertoire 
of adhesion molecules
that serve to mediate specific interactions with HSC (Tavassoli et 41., 
1968)'
It has been known for many years that the stomar tissues of the haematopoietic 
organs are
necessary for haematopoietic support and that they contribute to the 
direction of the type of
haematopoiesis which occurs ín situ (Chabannon et al', 1992)' Beginning with 
the early
studies of Dexter and coworkers it has been shown ttrat a murine liquid marTow 
culture
system that allowed both colony-forming and reconstituting haematopoietic 
progenitors to
be propagated for many months. It was stromal dependent and called the long-term 
bone
maûow culture (LTBMC) system that support either myelopoiesis or lymphopoiesis
(Whitlook et aI.,1982; Tavassoli et al., 1968). Long-term cell production in each case
depends on fonnation of an adhesion layer of cells which may be 
an in vitro counterpart to
the in vivo haematopoietic microenvironment that serves as a nurturing base 
for
proliferation and differentiation. In these culture, the HSC with the higbest 
renewal
8
potential either rest or and adhere to the stomal cells that are attached 
to the plastic
subsfiate (Andrews et al., 1989)'
I.2.4.2 STROMAL CELL TYPES
The cell population comprising the stroma in murine Dexter cultures 
consists of several
defined celt types as well as an uncharacterised fraction. The 
predominant plastic-adherent
cells in murine Dexter sfioma appears to be the macrophage, 
comprising approximately 70-
80% of adhesion cells (Gualtieri et al., 1984). The next most frequent 
is an alkaline
phosphatase-positive, pradipocytrc cell that is probably a fibroblast 
and may be the in vitro
analogue of the adventitial reticular cells describe d in vivo (Moore, 
1975)' tn addition wolf
and colleagues (1963) investigated that endothelial cells, another 
component of shoma'
However, there is a small number of plastic-adhesion cells 
(<5Vù that cannot be classified
specifically; the role of these cells in haematopoiesis is still 
undeterrrined'
l.2.4SPRoDUcTIoNoFcYToKIIl[EsBYSTROMALCELLS
In vitrothe role of stromal growth factor in regulating haematopoiesis in Dexter 
cultures
was contoversial. Stomal cells produce a wide variety of defined 
cytokines' Initially,
investigators had difñculty ascertaining colony-stimulating activities 
in the Dexter culture
but finarly, csF-r and undefined corony-stimurating activities were 
detected in conditioned
culture. A number of studies followed and showed ttnt shomal cells 
were capable of
producing a wide valiety of cytokines (Long et al', lgg2)' These are 
presented in Table I ' l '
I.2.SEXTRACELLULARMATRD(MOLECIILES
There is a fundamental postulate in cell biotogy that cells normally 
adherent ín vivo require
attachment and spreading in vitro to proliferate and to differentiate. 
Much research has
focused attention on the natu¡e of adhesive macromolecules in the extacellular 
matrix
(ECM) and the cha¡acteristics and corìsequences of the interaction with 
cell-surface
receptors @unidge et a1., 1983). Numerous bone 
ma¡row ECM molecules are produced
and secreted by epithelial cells, macrophages, fibroblasts 
(reticular, adventitial and barrier
cells), bone-lining mesenchymal cells, and hematopoietic 
cells present in the extravascular
haematopoietic cords @unidge et a1.,1988). The primary constituents 
of bone malrow
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TABLE 1.1 PRODUCTION OF CYTOKINES BY BM
STROMAL CELLS
BM stromal cells production of cytokines. Table 1.1 provides all definition for abbreviations.
Copy from long (eds), l992table 3'8, page of 60.
Clokine Cell Source lnducl-on Sludy
GM-CSF Murine stroma Detectable in normal
and inadiated lroma
and furlher induced bY
leclin. ll-l, and lilhium
Clone murine stromal lL-l and LPS induoe, not
líne constitulive
Human stroma ll-l increased by
inducing riborìuc{ease
actívity




Human manow Baseline and further
índuc€d'wilh ll--l
Ckrne murine slrornal lL-1 and LPS induce, not
li¡re conslih.¡live
CSF-1 Murir¡e FllA detecfat{e,
¡rrad¡aled and
nonirradated
Humar¡ marrow RIA detectable
lL-lP Longiterm human EUSA ir¡duced Ð ¡L€
q¡lt¡re
lL-3 l.lornul human stroma Polymerase cñain
¡eaclion
Norn¡al or irradialed Polymerase cfiain'
rurine slroma reaction
lL-l 1 Pr¡mde sùomal line
and PV-34
c-kit ligand Murine
TNF Bone marrow stroma lL-4 (d¡d not upregulate
expression of CSF-I
orTGF-Ê).
ll-4 pretreatment for 5
to 7 da¡æ induced
inhibitory activity






lL€ Human No constitutíve, ir¡crease
by lL-1c or TNF-a
Kitller et al-rr
Alberico et al. i989tæ
McGrath el al. 1987rs
Rennick et a¡- 1987r
Bagby et at- 1989165
l(tler et al.ts
Fibbe et at- 1988a2
Rennick et al. 19a7s
Fibbe et al. t98817
Kunhara et al- l990Pe
Barge et al- 1989rc6
lGttter el al.tg
Paul et al- 199Ot
Kitüer et al-rs
Pescf¡el et al. 1989167
Nemunaitis et al- 19894
ECM include collagens (type I, [, [, V, and XI), glycoproteins (fibronectin, laminin,
thrombospondin, haemonectin, and tenascin), and glycosaminoglycans (hyaluronic acid and
chondroitin dermatan, and heparan sulfates) (Williams et a1.,1991). It is thought that the
process of cell differentiation requires a number of cell divisions, and cell movement
involving the making and breaking of interactions with ECM. By serving as dynamic
physical intercellular "bridges," ECM molecules assist in facilitating cell-cell
communication by directly conveying information to haematopoietic cells though specific
cell-surface receptors and by co-localising and stabilising growth factor interactions
between stomal and haematopoietic cells (Yoder et ail., 1995; Verfaillier et ã1.,
1994;Williams 1993).
1.2.5.1 FIBROI\IECTIN
Fibronectin, a major component of bone marrow ECM, is considered to have an important
role in haematopoiesis (Dexte4l982). It is a multifr¡nctional glycoprotein that is essential
for embryogenesis (Potts et al., 1994) and is involved in cell migtation, adhesion,
proliferation, differentiation and interaction. Fibronectin is present in both soluble and
insoluble forms in body fluids and in tissue ECM. Fibronectin exists in a number of variant
forms that differ in sequence at three general regions of alternative splicing of its precursor
mRNA; for example, there can be 20 different forms of human fibronectin subunits. All
fibronectin molecules appear to contain the same basic functional domains shown in Eig
1.3.
Fibronectin is present in the bone marïo\il microenvironment, although significant
differences ¿ìcross species may exist in its degree of expression (Potts et al., 1994). In
confast, fibronectin expression appears limited to platelets, megakaryocytes, and walls of
blood vessels in normal human bone marow biopsy specimens (Lerat et a1., 1993).
HSC and committed progenitor cells predominantþ interact with fibronectin through
expression of cell-surface receptors belonging to the integrin superfamily. Schick et al,
1998, demonstrated a role for fibronectin in MKs maturation and platelet production.
Fibronectin was secreted by MKs and adhered to their surface. They also identifred the p
integrins VLA-5 on the MKs surface as the major integrin mediating the binding of MKs to
fibronectin. In addition, Sugahara and co-workers (1994) investigated the effects of
l0
FIG. I.3 FIBRONECTTN AND OTHER CELL INTERACTIVE
GLYCOPROTEINS
Function domains of fibronectin. This large glycoprotein is depicted 
as a dimer : of simila¡
but nonidentical subunits linked by a pair of carboxyl-terminal 
disulfide bonds- cell-binding
regions of sequenc e aÍe indicated along the top; the 75KD central celt-binding domain
contains the A¡g-Gly-sap (RGD) sequence and a synergy region 
that interacts synergistically
with the GGD sequence to mediate adhesion; the IIICS region 
contains the minimal active
sequence Leu-Aspval (LDÐ as well as Arg-Glu-val (REDV)' Copy 














fibronectin on the proliferation of a myloid leukemia cell line' M07E' 
and showed that
fibronectin is capabre of inducing apoptosis via its interaction wittì 
vLA'5, thus raising the
possibility that the fibronectin-vlA interaction may contibute, at least in part, to 
a
negative regulation of haematopoiesis'
I.2.6 HAEMATOPOTETIC CYTOKII\ES
It is well understood that haematopoietic cells proliferation and differentiation 
is contolled
by pol¡rpeptide growth factors (cytokines). within the past decade, approximately 
16
cytokines (11 interleukins, macrophage colony stimulating factor' erythropoietin'
granulocyte colony stimulating factor, granulocyte-macrophage colony 
stimulating factor' c-
kit ligand and y-interferon) have been identified, cloned and examined for 
their function in
haematopoietic cell development (Testa et al., 1993)' The haematopoietic 
cytokines consist
of a large and growing number of molectrles' predominantly identified 
to have stimulatory
or inhibitory effects on haematopoiesis. These cytokines include the 
colony forming-
stimulating factors (CSFs), which were first defined in clonal culture systems' 
the
interleukins (IL), which were first described in immunologic studies, and 
other protein
growth factors (ogaw4 1993). A large body of literature has shown that these 
cytokines
are produced by a variety of haematopoietic and stomal cells and 
have overlapping or
redundant effects on a variety of haematopoietic cells (Metcalf, 1993)' 
Ogawa has
categorised the csFs and ILs in terms of the relative maturity and 
lineage specificity of the
haematopoietic cells on which they have an effect (ogaw4 1993). The 
early acting factors
include stem cell factor SCF, c-kit ligand, steel factor,l"6, granulocyte CSF 
(G-CSF)' IL-
ll,IL-72 and ler¡kaemia inhibitory factors. The intermediate-acting, lineage-nonspecific
factors include SCF, IL-3, granulocyte-macrophage-CSF (GM-CSF), 
and IL-4' The late-
acting, lineage-specific factors include G-csF, IL-5, and erythropoietin'
scI. During the last few years, several groups have identified a novel cytokine termed 
c-
kit ligand, stem cell factor, mast cell gfowth factor or steel factor which 
is known to bind to




II-3.lnterleukin-3 (tr--3) was originally defined in mice as a factor 
that was released by a
certain monoc¡ic ler¡kaemia cell line (WEHI-3B) or by activated 
T cell, that stimulated
growth and differentiation of mast cells and precrusors of all haematopoietic 
lineages' In
vitro,effects of IL-3 are probably restricted to ttre pruripotential haematopoietic 
stem cell
and its derivatives, including the mature effector cells of certain lineages' 
In vivo' ['-3
functions as a link between the immune and haematopoietic systems, 
stimulating the
generation and the function of blood cells'
II--6. Testaand co-workers (1993) has described IL-6 as a multifi¡nctional 
cytokine acting
on a wide variety of cens. It has been caned by various names 
rclated to the biological
function. In vitro,Il-6 induces megakaryocyte maturation and T ccll 
proliferation (Arai et
a1.,1990). In vivo,it induces megakaryocyte mafuration in mice 
and monkeys'
Thrombopoìctín. T\rombopoietin or Megakaryocyte Growth and Development 
Factor
(MGDF) has a key role in the development of megakaryocytes' 
Its role will be discussed in
detail in the section on Megakaryopoiesis Fig'l'4'
t2
TABLE 1.2 TIIE MAJOR HAEMATOPOIETIC
GROWTHFACTORS






CFL-GEMM, BFU-E, CFU-GM, CFU-Meg, CFU-
Eos, CFU-M,GM-CSF,CFU-GM, BFU-E, Czu-GEMM' CFU-
Eos, CFU- M"g, Czu-G, Czu-M, maturing neuüophils'
monocytes, eosinoPhils
B cells, plasma cells
Early stem/progenitor cells, megakaryocytes
CSF, colonY stimulation factor; CFU'








In the bone marrow, haematopoietic progenitor cells 
proliferate and diflerentiate within a
specific microenvironment consisting of stromal cells and their 
associated exhacellular
matrix and various secreted cytokines. Each has functional 
significance for both mature and
developing blood cells. In essence, the interactions between the HSCs 
and their
microenvironment can be simplified into three categories: cell*ell, 
cell-exEacellular
matrix, and cell-cYtokine.
1.3.1 IIAEMATOPOIETIC STEM CELL AI\ID
STROMAL CELL INTERACTIONS
The method by vihich stromal cells regUlate haematopoiesis 
is believed to occur througþ
cell-cell contact interactions and release of growth factors' Cetl-cell 
interactions are
concern with the cytoadhesive capacities of haematopoietic 
progenitor cells for stromal
cells layers and vice versa @exter, 1932). The proliferation 
and in vito expansion of HSC
has been the focus of many investigations and cell culnre systems' 
The Dexter culture
system @exter et al., lg77) provides an important tool to 
study the mechanisms of
haematopoietic-stomal cells interactions. Heterogenous 
adherent cell layers derived from
BM shoma (endothelial cells, macrophages/monocytes, fibroblasts, 
adþcytes etc) have
been shown to support long'term bone marrow culture' This 
cultu¡e system showed that
the proliferation and differentiation of haematopoietic 
progenitor cells involves cell-cell
interaction (Verfaillie et a1., 1 990)'
Lichtnan was one of the first to observe stromar cell-haematopoietic 
cell interactions as
seen in the developing erythroblastic islands, which consist 
of a central macrophage
surrounded by maturing erythroblasts (Lichtnan 1984)' This 
tight adhesion results from
fibronectin-mediated attachment (Tsai et a1.,1987)' simmons 
and co-workers described
vascular cell adhesion molecule-l expressed by bone marrow 
stromal cells mediates the
l4
binding of haematopoietic progenitor cells (Simmons et aI', 1992)' At the 
primitive
haematopoietic cell level, studies by Gordon and colleagues documented 
that human blast-
colony fonning cells adhere to preformed stromal cell layers (Gordon 
et al', 1990)' Other
studies have shown that cD34 selected ma,,ow cell popurations attached 
to seomal cell
layers, and that the attached cells a¡e enriched for granulocyte/macrophage 
progenitor cells
(Liesveld et al., 19S9). In the murine system, highly enriched spleen colony-fonning 
cells
(CFU-S), cultured on sEomal cell layers, ptoliferate and differentiate into 
haematopoietic
cells (Lichturan, 1981). Such fn vifro studies highlight the abilþ of the stromal
microenvironment to regulate haematopoiesis tbrougþ a complex interplay of
haematopoietic cells with soluble cytokines, ECM, and stromal cells' Stomal 
cells play a
important role in the survival, proliferation and differentiation of CD34* 
progenitor cells
and potentially influence the self-renewal of pluripotent progenitors 
cells'
MKs progenitors grow and differentiate in bone malrow, where the 
microenvironment play
a crucial role in megakaryopoiesis. A specific association noted in ma¡row is the
connection of megakaryocytes with the venous sinus endothelial cells 
(Liesveld et al"
1989). This relationship may be mediated by thrombospondin 
(a multifunctional adhesion
protein) in the exhacellular matrix. Thrombospondin can bind fibrinogen and 
together
thereby bridge the platelet gþoprotein trb/Itra integrin receptors on megakaryocyte 
and
their progenitors with stromal cells Table 1.3. Although the importance of 
adhesive
interactions in haematopoiesis has becn well studied, little is known about 
the role of
adhesion molec'res in MK differentiation. The integrins and associated 
tetraspan supef
famity molecules may be critical for the interactions between MKs 
progenitors and stomal
cells during megakaryoPoiesis.
I.3.2 HAEMATOPOIETIC STEM CELL AI\D EXTRACELLIILAR
MATRD( (ECM) INTERACTIONS
It is widely thought that the interaction of HSCs and bone malrow extacellular 
matrix is
cruciar for the deveropment of mature blood celrs. Experimental 
proof of this hypothesis
focused attention on the nature of adhesive macfomolecules in the ECM and 
the
characteristics and consequences of their interaction with cell-surface 
receptors. The major
l5
TABLE 1.3 HAEMATOPOIETIC CELL: CELL INTERACTIONS
Table 1.3 summa¡ises haematopoietic cell: cell interactions. These cytoadhesion molecules
mediate both antigen recognition and cell-cell communication. Both the immunoglobulin and
integrins superfamilies are involved. Copy from Long (eds), 1992. Table 2-2,pa9e26.
mediating specific interactions














macrophage, T cell CD8, TCR






























gp150,95 macroPhages, neutro VtA4
phils
Fibronectin receptor BFGE though fìbronectin
reticulocytes







sialyl-Lewis x2 endothelial cells
neutroPhils, tumor
Lewis x (CD15) cells,endothelial cells
neutrophils
adhesive macromolecules for epithelial and mesenchymal celrs 
include fibronectin (F1{),
vitronectin, larnini4 entactin, the fibrillar collagens (types I' II' m' V' and )([) 
and the
collagen in basement membranes (type [V); these component interactions 
depend on
va¡ious cell-surface recePtors'
Early in vivo work by Wolf and Trenton (Zuckerman et al', l9S3) 
provided evidence that
components of the microenvironmeût are fespollsible for 
the gfanulocytic predominance of
bone marow haematopoiesis and the erythrocytic predominance 
of the spleen' Dexter and
co-workers showed thzt in vitro development of a suitable adherent 
populæion of bone
ma¡rowderived cells is essential for the maintenance of cell proliferation 
and
differentiation in long-term bone manow culture system' Zuckerman 
and colleagues
(Zuckerman et al., 1983) demonshated thæ specific ECM components 
such as fibronectin'
laminin and various collagens and proteoglycans were 
present in long-term malÏow cultures
and the deposition of these proteins coincided with the onset of hematopoietic 
cell
production. ECM components such as fibronectin have been detected 
by
immunohistochemical techniques on substrate attachment surfaces 
of mouse mfuÏo\¡r
snomat cells and at the sites of inæraction between these cells and 
developing
granulocytes/monocytes (Tsai et al., 1937). Tsai also reports that 
primitive erythroid
progenitors have been found to bind to the cell-binding domain' A number of
investigations point to the influence of ECM in promoting cellular development'
Gospodarowicz (1980) demonstated that ECM geatty affects 
comeal endothelial cell
proliferatio n in vitro. Table 1.4 shows the function of both previously 
known and newly
identified ECM components in haematopoietic cell 
production. Of major importance to the
present study is the interaction of fibronectin with megakaryocytes 
via the p integ¡ins'
1.3.3 IIAEMATOPOIETIC STEM CELL AI\D
GROWTH FACTOR INTERACTIONS
Most haematopoietic stem cells are quiescent in the Go stage 
of the cell cycle' Certatn
haematopoietic cytokines can bind to their corresponding 
receptors on the stem cell sutface'
shortening the Go stage of the cell cycle, and stimulating 
celt division' (Arai et al" 1990)'
More recently, two early acting synergistic cytokines, derived 
from stroma (tr--11 and
t6






































Table 1.4 shows haematopoietic cell and extracellular matrix interactions. This study
identified the function of matrix components in haematopoietic cell cytoadhesion. Copy from
Long (eds),1992.
SCF), have been shown to shorten the Go period of early progenitors 
(Tsuji et al', 1992)'
within the past decade, 16 haematopoietic cytokines have been identified. 
These include 11
interleukins, macrophage-CsF, erythropoietin, granulocyte 
(G)-CSF' GM-CSF' and
gamma_interferon. The recent cloning of the receptors for these cytokines 
has indicated that
a number of these receptors have amino acid homologies, suggesting 
that they are members
of one or mo¡e gene families (Arai et al., 1990)' Like other cell surface 
receptors'
haematopoietic cytokine receptors stnrctt¡ally contain a large extacellular 
domain' a
transmembrane regon" and a cytoplasmic domain, the sequence 
of uihich seeflrs to be
unique (Arai et at., 1990). The extracellular domains of IL-l, IL-6, and 
gamma-interferon
receptors contain sequence homologies with the immwroglobulin 
gene superfarnily' weak
but significant amino acid sequence similarities exist funong the 
IL-2 (p chain)' L'6'L-3'





Megakaryocytes (MKs) are derived from an undifferentiated 
HSC, a single MK giving rise
to approximately 2000 platelets which play an important 
role in blood coagulation (Atan
1995). MKs represent only 0.05% of ttre cells in bone marrow 
(llarker' 1968)' In
megakaryocytopoiesis, committed MK progenitor cells (CFU-MK) proliferate 
and
differentiate into MKs. MK development in turn is characterised by nucleaf
poþtoidisation and cytoplasmic maturation vihich eventually leads 
to platelet release
(Corash et a1., 19S9). This process has long been thougbt to be 
regulated by a lineage-
specific humoral factor catled thrombopoietin (Tavassoli 
et at., 1968)' Even thougþ the role
of interactions of HSC \ rith bone ma¡row stoma has been widely 
studied in the
differentiation of erytrfoid and myelomonocytic cells, there 
have been no studies of the
eflects of stromal cells or ECM on the differentiation of MKs' It is 
clea¡ that a knowledge
of megakaryopoiesis is important for understanding the pathophysiology 
of acquired and
congenital qualitative and quantitative platelet disorders' 
Iluring the last 15 years the study
of megakaryopoiesis has increasingly shifted away fiom morphologically 
based studies and
become more sophisticated. The understanding of the development 
of MKs has been
extended by culture of MK progenitors invitro(Vainchenker et 
a1', lg7g),the isolation and
emichment of relatively pure, viable populations of MKs and 
the use of molecular methods
such as the polymerase chain reaction and insirz hybridisation 
(Gewirø, 1990)' A major
advance has been the use of recombinant human haematopoietic 
growth factors in vitro to
generate MK progenitor cells from stem cell population' However' 
little is known about the
mechanisms which regulate platelet production from MKs'
The c-Mpl receptor ligand, thrombopoietin (TPO)' has
megakaryocytopoiesis and platelet production as shown 
by several in vìtro and in vivo
studies(Kaushansþ,\995;\Mendlingetal''1994;Desauvageetal''1994)'Itsrecent
çlening has greatþ enhanced progress in the understanding 
of MK development' Isolation
and culture of CD34* cells with TPO has been used successfully 
to expand the MKs
a significant role in
t8
population by cultt'ing CD34* cells derived from bone ma¡row, 
cord blood and peripheral
blood.
The role of adhesive interactions with the extraceltular matrix 
of the bone marow stroma
has not been widely studied in the MK rineage. Recently, 
pascar and co-workers (1997)
reported on the expression and function of receptors for extracellular 
matrix molecules in
the differentiation of hr¡man lvKs in vitro. The results of this study suggested 
that a
proportion of CFU-MK are adherent to fibronectin" indicating 
that receptors (most probably
\||A4) for this molecule are already present' \[[,A-4 may be involved 
in the adhesion of
immature MKs on fibronectin and may then be replaced 
by wA-5 in the final stages of
maturation. Although the expression and function of adhesion molecule 
receptors
(integ¡ins) of the pr family have been studied in the differentiation 
of erytl'oid cells, very
rittte is known concerning their role in the differcntiation 
of megakaryocytic lineage cells'
The development of an efficient in vitro serum-free liquid culture 
technique for the
production of MKs enables the study of the expression and 
function of adhesion molecule
for extacellular matrix and stromal cells in the differentiation 
of MKs'
l.4.2MEGAKAR]TOCYTEMATURATIONINwTRo
MKs are derived from an undifferentiated pluripotent haematopoietic 
stem cell (visser et
al., 1984). Once lineage commitment occurs' MK progenitor 
cells occupy the first
..comparbnent." Further proliferation and differentiation ampliff the numbers 
of MKs in
the ma¡row (Goodmao 1960). only a very smail numbers 
of lineage committed progenitor
cells a¡e present in the bone ma¡row Fiel'4'
progenitors of MKs can not be identified directþ on the basis of their 
morphological
features, but can be detected as colonies of differentiated 
progeny in va¡ious culture
systems. The most immature progenitor cell is the megakaryocyte 
Burst Forming unit
(BFU-MK). This colony requires about 21 days in culture to 
develop and is composed of
multiple clusters of megakaryocytic cells which often 
number in the hundreds (Long' et al''
1985). The next most immatr¡re progenitor cell is the 
Megakaryocle Colony Forming Unit
(cFu-MK). The CFU-MK is a more mature cell than the BFU-MK 
and was the first MK
progenitor cell to be identified. (Mazur et a1.,1981)' Czu-MK 
gives rise to single cluster
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FIG. 1.4 PROPOSED SCI{EMA OF HUMAN MEGAKARYOCYTE
MATURATION
Fig. 1.4 presents a schematic diagram of the events related to the development 
of MK in
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coworkers with identification of colonies using an immunochemical 
identification' The
MKs identified incruded those not yet morphorogicany identifiable 
(Mazur et al., 1981).
This method utilised a highly specific rabbit anti-platelet glycoprotein 
antiserum in an
indirect immuno-fluorescence assay'
1.4.3 REGI]LATION OF MEGAKARYOCYTE
DEVELOPMENT
The regulation of MK development has been discussed in tenns 
of regulators that act early
in proliferation at the level of the progenitor cells, and those 
that act late upon terminally
differentiating cells (williams et al., 1982). The activity responsible 
for this stimulation
was termed "megakaryocyte colony stimulating factor or activity"' 
Now known as
tbrombopoietin (TPO) or megakaryocyte growttr and development 
factor (MGDF)' this
activity plays a major role in regulating megakaryocyte 
production' other cytokines known
to impact on cells of this lineage include ScF,IL-3,IL-6 and IL.l1.
For over thirty years, many investigators had been searching 
for a lineage-specific
megakaryocyte proliferation and differentiation growth factor' Although 
a variety of
cytokines do have megakaryocyte stimulating activity 
(MK-CSA)' none was found to be a
specific MK stimutant and none had the potency of thrombocytopenic 
plasma' In the past'
maûy investigators believed that they had discovered 
the identity of this growth factor,
termed thrombopoietin" but efforts to purity this substance 
to homogeneity from plasma
proved unsuccessful (Hoffinan et al., 1985). However, :Ir-lgg4 
three groups successfully
isolated, cloned and characterised a specific MK gfowth and 
development factor which was
called c-Mpl ligand or thrombopoietin (TPO)' The commercial 
production of a recombinant
forrr, such as Amgen's megakaryocyte growth and development 
factor (MGDF) has been a
natural outcome of these discoveries'
The use of recombinant c-Mpl ligand in experiments with 
factor dependent MK cell lines in
culture has provide d in vitro proof of its thrombopoietic activity ' In vitro' it has 
been
shown that c-Mpl ligand is capable of inducing MK colony 
formation and enhancing MK
maturation.c.Mplligandhasbeenshowntospecificallyinduce(CFU-MK)formationfrom
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unfuctionated murine bone marrow cells, mr¡rine fetal 
liver cells, and human bone marow
and peripheral blood CD34+ cells. Other studies (Sauvage 
et al" 1994) indicated that the
serum of iradiated mice was able to induce proliferative activity 
in a MK cell line
transduced with the c-Mpl gene. However, when a soluble 
c-Mpl receptor molecule was
added to the aplastic mu¡ine serufn, its MK-CSA was eliminated' 
This implied that the
specific MK-CSA of the aptastic serum was mediated at 
least in part by the c-Mpl ligand
(Wending et al., lg94). In 1994, Gurney demonstated that ttre specific 
role of the c-Mpl
ligand in thrombopoiesis has come from a mor¡se model 
in vivo (Gumey et al'' 1994)' This
group generated c-Mpl deficient mice by gene targeting and 
indicated thaf these mice had
an[So/oreduction in their platelet counts compared to 
normal controls' uihile the other cells
such as red cells, and total and diff[erential white cell cotrnts 
were unaffected' Furthermore'
these mice had elevated levels of thrombopoietin (c-Mpl ligand)' 
but Il-3' IL-6 and GM-
CSF were not increased. These results strongly indicated 
that megakaryocyte g¡owth and
development factor is a lineage-specific regulatory factor 
for megakaryopoiesis and platelet
production.
In vitro studies suggest that c-Mpl ligand has the properties of 
MK colony stimulating
factor and TPO for the following reasons:
(a) The c-Mpl ligand is capable of inducing MK colony formation 
and MK proliferation of
CD34* of human and murine haematopoietic stem cells 
(Kaushansky' 1995)'
(b) The biologic level of the molecule is increased in plasma from animals 
made
thrombocytopenic either by irradiation or by immune 
prateret destruction (wending et al.,
te94).
Evidence for the humoral regulation of megakaryopoiesis was first 
obtained from
observation that serum or prasm4 derived from animars 
rendered thrombocytopenic by
irradiation, was capable of stimulating MK progenitor cell 
proliferation and maturation'
Although MGDF appeafs to play a major role in regutating 
MK and platelet production' it
hasbeenknownthatothercytokinessuchaslL-3@runoeta1.,1989),IL-6(Briddelletal.,
tgg2),SCF Qshbashi et al., 1990), GM-CSF (Xu 
et a|., |gg4),IL-11 (V/aldburger et al.,
lgg4),and IL-12 (Lotem et al., 1989) can regulate MK development' 
However' it was not
believed that any of these cytokines acted specifically 
on the MK cells' IL-3 seems to be
the most potent of these cytokines, at least in murine systems 
where the MK-CSA of
2l
mitogen stimulaæd spreen cell conditioned media is neutrarised 
if anti'Il-3 antibodies are
added.
IL-6 has been shown to induce MK progenitor cell proliferation as 
well as maturation'
Some reports showed that MK-csA of IL-3 mediated by IL-6 as antibody 
against murine
IL-6 neutralised the MK-CSA of mr¡¡ine IL-3 @emetri et al., 
1993)' In patients receiving
high dose chemotherapy for metastatic safcoma and lung cancer' 
IL-6 has reduced the
decrine in platelet count and hastened the recovery of platerets 
to baseline tevel (Tanaka et
a1.,1992).
Known as steel factor (sLF) or c-kit ligan4 scF is expressed by 
bone mafrow stromal
cells, fibroblasts and fetal liver cells. scF shows modest effects 
on early myeloid and
lymphoid cells, but it is a multi-lineage factor which synergises dramaticalty 
with other
cyùokines. Rasko and colleges indicated that scF sig¡ificantþ stimulated 
the proliferative
process in both mu¡ine and human czu-MK in serum-free cultue with IL-3, 
and that the
main activity of IL-6 is the promotion of MK maturation @asko et 
al" 1997)'
I.4.4 MEGAKARYOCYTE PMNOTYPE
The central and most powerful advancement in the analysis of cell surface 
marker
expression was the development of highly specific monoclonal 
antibodies (MoAbs) from
1975. MoAbs suitable for the identification of MKs afe now available'
l. cD61. The cD 61 antigen þlatelet glycoprotein Gplna) is the 110 kDa integrin B3
subunit which is involved in plateret aggregation and adhesion 
to extracertula¡ matrix. cD
61 is expressed on megakaryocytes and platelets and also 
on monocytes' macrophages and
endothelial cells (Vinci et al., 1984). Evaluation of MKs lineage 
markers showed that the
antigenic expression of lineage markers are distinctive in the developmental 
seqence of




2. CD4I.The CD41 antigen is the integrin otrb chain of platelet 
gþoprotein GPIIb/Itra' It
is the major integrin on platelets and is important for MK and 
platelet adhesion and
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aggregation. cD41 binds to multiple sites on fibronectin and is important 
for platelet
adhesion, it is believed to be a specific antigen for MKs (Tomer et al', 
1988)'
3.cD42b. CD42(GpIb) is a 160 kDa protein" mediating platelet adherence and 
aggregation
at sites of vascular damage. CD4zbinds to von Willebrand factor, and 
is also a receptor for
thrombin @efridge et al., 1988). Interaction of subendothelial 
vwF and ctp Ib results in
boththe adhesion and subsequent activation of platelets and MKs 
(Baftha et al'' 1993)
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1.5 ADIIESION MOLECULES AI\D
HAEMATOPOIESIS
1.5.1 INTRODUCTION : THE F'UNCTION OF
ADIIT',SION MOLECT]LE S
cellular adhesion plays a cenúal role in many biological processes 
such as cell migration'
cell-cell interaction, and morphogenesis (EdelnarU 1985)' Adhesion is of 
fundamental
importance to a cell. It provides anchorage, cues for migratioU and signals 
for growth and
differentiation. There are two basic types of cell adhesion: ECM adhesion 
and cell+ell
adhesion. Adhesion is involved in many ctinical diseascs, for instance, vascular
thrombosis, inflammatory pnocess, tumouf metastasis, bacterial 
and parasitic infections'
Adhesion is mediated by adhesion molecules wtrich are essential for 
the above fi¡nctions'
They are also believed to be important in the regulation of haematopoiesis 
(Hanspal,1997)'
Adhesion molecules a¡e the cell surface sûrrctures that ptay a direct 
mechanical role in cell
binding. cell adhesion occurs when a plasma membrane adhesion receptor 
interacts with a
molecule in the exEacellular matrix or on the neighbowing cell and when 
the liganded
receptor forms a connection with the cell's own cytoskeleton'@delmen 
et al'' 1991)'
Over the last decade a major effort has been made to identiÛ many üansmembrane
glycoprotein receptors or cell adhesion molecules (cAMs)' These mediate the 
adhesion
between cell and cell, cell and ECM proteins @detman et al', 1991)' Va¡ious 
adhesion
molecules of different families have been implicated in the interactions of 
developing
haematopoietic progenitors and their microenvironment. Four 
main fa¡nilies of adhesion
molecules, the integrin superfamily, cadherin, immunoglobutin zuperfamily 
and the
selectins, have been reported (Ilynes, lgg2) Fig l'5' Only the integrin superfamily 
was
studied in the present work. Numerous groups have studied integrin 
and Ig superfamies of
adhesion molecules, particularty, and some studies have indicated 
that the Þr OLA) farnily
of adhesion molecules might be important in the regulation 
of haematopoiesis (Miyaka et
al., 1991; Yanai et al., 1996)'
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FIG. 1.5 THE FOUR MAIOR CLASSES OF ADI{ESION
RECEPTORS
N-cadherin is one of the adhesion molecules mediating the outgrowth of neurites. The second
major class, the immunoblobulin superfarnily,frîy also mediatehomophilicinteractions. The
third major class, integrins a¡e heterodimers whose two chains contribute to ligand binding,
finally, the selectins, which have a distal calcium dependent lectin interact with carbohydrate





Because adhesion molecules play a major part in cell-cell and cell-matix 
interaction' these
adhesive inæractions are important in the regulation of HSC maturatior¡ 
and the direction
of HSC migration througþ tissues. Other studies have shown that CAMs 
participate in the
regulation of proliferation and differentiation @osales et al', 1995)'
In the bone marrow, haematopoietic progenitor cells proliferate and differentiate 
within a
specific microenvironment consisting of stomal cells, exhacellular matix 
(ECM) and
various secreted cytokines @onshkind 1990). close interactions of the developing
progenitor cells with this microenvironment is needed to control the haematopoietic 
cells
proliferation and differentiation (Klein" I 995)'
I.5.2 INTEGRIN ST]PERFAMILY
Integrins ar€ a family of celr surface proteins that mediate cell adhesion- The 
integrin
family appears to be the primary mediators of cellular-extracellular matix adhesion' 
and
also serves as one of the many families of molecules active in cell-cell 
adhesion'
Integrins arc c[B heterodimeric transmembrane proteins comprising of at 
least 14 c[ chains
and g p chains which are expressed by epithelial cells as well as other cell 
types. Tablel'S'
Integrins are classified according to their type of beta subr¡nits (Þr, Þ2, 
p3)' based on the
sharing of a common p chain. It is clea¡ that some c[ chains can associate with 
more than
one p chain.
ft" p, of very late activation antigen (vLA) farnity consists of at least six different
heterodimers with a coûlmon 130 kd Br chain and six distinct a subunits. They are
generally involved in adhesion with EcM molecules and may flrnction as receptors 
for
collagen NLA-1, wA-3), fibronectin (vLA-3, VLA-4, VLA-S) and laminin 
(vLA-6)
(llynes, tggÌ).
In the pz or leucocyte cell adhesion molecule (Leu-CAM) family there 
are three members:
LFA-I (CDlla), MAC-I (cDllb) and p150',95 (CDl1c)- These have a common þ2 
cl":lan
and a chains of 175,165 and 150 kd respectively). They mediate leucocyte homotypic
adhesion through a specific interaction with ICAM-I (LFA-l) (Hogg et al', 
1989)' The
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.were on monocyües, in which orraÞz can be activated by adherence to
fibronectin.
fr" Þr, or cytoadhesion family, includes at least gptrb/Itra the 
platelet receptor for
fibronectiq fibrinoger¡ and von Willebrand factor, and the 
receptor for vitronectin (VNR);
these molecules also consist of a common p3 subrmit onrlRÞ/æma) 
and of distinct c[
subr¡nits (Ginsberg et al., 1988)
Another important function of the integrin heterodimers 
is that they are likely to participate
in the signal transduction pathways mediating information 
about the structure of the cells
(Schwartz, lgg2). The exact molecular mechanism of signal 
transduction via integrins is
still not clear. However, the fact that the cell surface 
integrin pattem does not only regulate
the adhesion properties of a cell but can also significantly 
influence cell behavior¡¡ increases
the interest in studying the factors regutating integrin 
expression'
The inægrin molecules mediate adhesion by three mechanisms 
of interaction: cell-cell' cell-
matrix and cell-soluble cytokines. Integrins function 
as receptors for exfiacellular matrix
proteins including collagens, fibronectin and laminin 
(Hynes, 1992)' Evidence is emerging
that individual integrin receptors mediate distinct functions 
and trigger distinct signauing
pathways ([Iynes, 1992).
Most integrin receptors recognise a tripeptide sequence 
RGD on their respective ligands
withtheexceptionofcDls/CDlla(LFA-I)@uoslahtietal''1987)'Theprecise
mechanism of how this simple fipeptide is utilised by 
so many receptors for different
adhesion and signarling processes is not known. This thesis 
only describes the p1 or very
later antigen (vLA) and mainly focuses on vLA-4 and vLA-5' 
and cD 61 (integrin Þg
subunit) as referred to previously'
1.5.2.1 vLA4 (CD49d' c[¿Þr)
The wA4 (CD4gd) is the major mediator of ce[-exFacellular matrix interactions 
and
homing.CD4gdisnowknowntobehighlyexpressedonTcells'Bcells'andmonocytes'
The vLA4 is different from other vLA proteins and has been implicated 
as a cell-cell
adhesion receptor (Hemler, 1990). The VLA4 integrin shows 
an interesting dual
specificity in that it can also bind to fibronectin (Mould 
et a1'' 1990)' VLA-4 (cr+Fr) which
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binds to the GGD segment of fibronectiru a¡e believed to be important 
mediators of direct
interactions between haematopoietic progenitor cells and BM microenvironment 
(Teixido
et al., ]992;Levesque et al., 1995). Recent work by Schick and coworkers 
(1998) has
shown that the integrin involved in the adhesion of MKs to fibronectin and 
fibrinogen'
\rLA-4 and its co- or counterreceptor, vascular cytoadhesion molecule 
(VCAM)-l' play an
important role in a wide variety of interactions. Adhesion molecules 
in addition to VLA4
(cqÞr) have been described on cD34+ cells, süomal cell-derived proteins such 
as
haemonectin and proteoglycans or cell-cell interaction mediated by endogenous 
lectin
(Simmons et al., lgg2). Pascal and his colleagues have reported that expression 
and
fi¡nction of receptors for exhacellula¡ matix molecures are invorved 
in the differentiation
of human megakaryocytes in vitro. In particular VLA4 seems to be involved 
in the
adhesion of immature MKs to fibronectin and is then replaced by 
wA-5 in the final stages
of maturation (Pascal et al., 1997)'
1.52.2 VLA-5 (CD49c, asÞr)
The role ofwA-5 in attachment of monocytes to fibronectin is well established 
(wayner et
al., 1989). VLA,5-like strucfi¡¡es of human monocytes have been 
eluted !\'ith RGD (Arg-
Gly-Asp) peptides from fibronectin fragment affinity columns' wA-5 pfoper|y 
is the
protot¡pe fibronectin receptor initialty isolated from an osteosa¡coma cell 
line by
absorption on fibronectin sepharose and elution with RGD peptide' 
vLA-5 was
independently characterised on the leukaemic cell lines K-562 andlJ-937' 
where it was
shown to be the fifth distinct member of the vLA protein fa'ily (wayner et al'' 
1988)'
Rosemblatt and coworkers (1991) have demonstrated that co-expression 
of two fibronectin
receptors, wA4 and vLA-S, by immature human erytt'oblastic precursor cells, suggested
that the adhesion to fibronectin first increases during early stages of erythroid
differentiatiorL and is subsequentþ lost with terminal maturation'
Rosemblatt and coworkers, (1991), elucidated the role of the two 
fibronectin receptors'
wA4 and vLA-5. Both vLA4 and wA-5 bind fibronectin. vLA-4 acts as a receptor
for the cs-l region of this molecule and recognises vcAM-l on activated 
endothelial cells'







t.6 TRANSMEMBRANE 4 OR
TETRASPAN SUPERFAMILY (TM4SF)
I.6.I INTRODUCTION
It has recently been shown that the transmembrane 4 superfamily (TMaSF) 
of membrane
proteins (also called tetraspan zuperfamily) comprises a grorp of cell-surface 
proteins that
are characterised by the presence of four hydrophobic domains, 
raùich af€ pfesumed to be
membrane spanning (Wfight et al., lgg4). It seems likely that they mediate sig¡ral
transduction events that play a role in the regutation of ceil developmen! 
activation' growth
and motitity @erdiæhevski et al., 1995). Unlike the other 
protein superfamilies, such as
immunoglobulin and integrin superfamilies involved in cell'surface recognition and
adhesion events, the TM4 SF role is not yet clear. This current work 
will examine any
significant interactions between TM4SF and the integrin superfamily 
and whether or not the
TM4SF associates with Pl integrin' Cwright et al', 1994)'
1.6.1.lTHETETRASPAI\ISI]PERrAIvflLYFI.]NCTION
The precise biochemical fi¡nction of the TM4SF is not known, 
althougþ the data currentþ
availabte summa¡ised-inJable-1.6 suggest a role for this superfarnily 
in the regulation of
cell developmen! proliferation, activation and motility' Roberts and his co-workers'
(1995), have shown that Anti-cDg MAb are able to induce platelet activation 
and mediator
release by crosslinking CD9. Olweus and his colleagues also demonstrated 
that expression
of signal transduction events has been modified in B-cells, 
granulocytes, and monocytes by
anti-CD53 monoclonal antibody (Olweus et a1', 1993)'
A potential role for tetraspans in modulating adhesion events has been 
fi¡rther supported by
subsequent studies higþighting their associations with integdns 
of the p1 fanily' CD9 is a
24y,Damembrane glycoprotein expressed on the surface of 
human platelets and potentially
involved in cellular activation and adhesion functions' Slupsþ and 
his co-workers have
shown that cD9 is associated \ /ith the otrbpr complex in platelets 
(slupsky et al'' 1989)'
Thus cD9 is reported to associate with small GTP binding proteins 
in platelets and
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TABLE I.6 TT{ETANSMEMBERANE 4 SUPERFAMILY
The TM4SF molecules remain a zuperfamily in search of a ñ¡nction: 
possible roles
include coupling to signal trasduction pathways or involvement in cell 
proliferation
and activation. Copy from Wrigbt et al', 1994'
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transfection of cD9 into Raji cells induces phosphorylation of a 110 
kD protein uihen cells
are plated on integrin ligands (Shaw et al', 1995)'
cD53 is a pan-leukocyte gþoprotein which is another member of 
the recentþ described
TM4SF of membrane. In the rat, CD53 is expressed on all peripherat 
leukocytes but on
only 12% of thymocytes. Remarkably, expression is absent on the vast majority 
of
CD4*CD8* th¡anocytes, which are cells that are destined to die in the 
thymus' The
immature cD+-cD8- cells, and the matr¡re singte positive cells, 
do express cD53' For
exanrple, signal transduction througb cD53 has been demonsEated 
by the use of human
anti-cD53 monoclonal antibodies which car¡se calcir¡m fluxes 
in B cells, monocytes and
granulocytes (olweus et al., 1993). It is not known from these str¡clies 
whetber sipnalling
through cD53 requires co-ligation. since cD53+ ceils account for 
all thymocytes that
proliferate in response to alloantigens and lectins, CD53 may mark those 
thymocyÛes that
are on the differentiation pathway to forming immunocompetent 
T cetts Cvfright et al',
re94).
CD63 belongs to the TM4 superfamily of membrane proteins' Previous 
results have
suggested that cD63 may play an important role in the regulation 
of melanoma (Radford et
al., 1996). CD63 is one of the major components of lysosome 
membranes' It has a 53 kDa
portion that is translocated to the plasma membrane after platelet activation' 
cD63 is a
marker for early stages of tumour progression of melanoma 
but is not detected on normal
tissue melanocytes and is weak or absent in advanced stages of 
melanoma (Radford et al"
1ee6).
CDl5l(tetrspan-plateleQalsoisamemberofthetetraspansuperfamilY'andisexpressed
on MK and platelets. Recently a cDNA clone encoding a27'kD 
protein PETA-3 þlatelet
endothelial tetaspan antigen-3) was isorated in Ashman's raboratory 
(Fitter et al., 1995).
The function is similar to other tetraspan superfamily and it induces 
Fc dependent platelet
aggregation and mediator release (Roberts et al., 1995). Ashman's 
goup has shown that
the association of cD151 \,rrith cD49c on endothelia cells and 
capillary fonnation in vitro'
indicated that cD151 might induce cell-cerl adhesion by activating 
*outside-in" signalling
pathways that indirectly up-regulated other adhesive mechanisms' 
cDl5l may play a role
in modulating endothelial cell function'
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Expression of certain TM4SFs is altered when cells are gfowing 
or activated' suggesting a
function in regulation of ce|l growttr- CD9, CD53, and CD63 are all up regulated 
on
activation of lymphocytes. Four of the TM4SF members have been shown 
to couple to
signal transduction pathways Cwright et al', L994)
I.6.I.2 CHARACTERISATIONOF'TIMCELLSTJRX'ACERELATIONSHIP
BETWEEN INTEGRINS AND TETRASPAI\ SI]PERFAMILY
The relationship of integrin signatting to tetraspan superfamily is not 
fully understood' It
has recently been shown tlrat several members of the tetraspan 
superfa¡ily' including CD9'
a¡e associated wifhVLA4 @ubinstein et al., lgg4) and for CD63' associated 
with each
other and dü P, integrins @erdirchevski et at., 1995)' Furthermore' CD9' CD63 and
CDBI were demonstrated to associate with each other and cr¡Þr to 
form tetraspar/ integdn
and teüaspan/tetraspan/integrin complexes by immunoprecipitation' @erditchevski 
et al"
Lee6).
More recently, schick and coneges reported that integrins are involved 
in the adhesion of
megakaryocytes to flrbronectin and fibrinogen" and showed that tlre adhesion 
of MK to
fibronectin was primarily inhibited by an anti-vlA-5 antibody. Thus, wA-5 is 
the major
integrin involved in the binding of MK to fibronectin (Schick et al" 1998)'
yanai and co-works (1994), demonstrated a role for integrin vLA4 in stroma-dependent
erythropoiesis. The development of the erythroid cells on stroma 
cells was inhibited by
anti-wA4 integrin antibody, but not by vLA-5 antibody although the erytbroid 
cells
express both VLA4 and VLA-5'
However, as far as can be ascertained the relationship between 
inægrins and tetaspan
superfamily on MKs development has not been reported. The aim 
of this thesis is to provide




It is evident from the literature review that the role of the haematopoietic 
microenvironment
in megakaryopoiesis is not well studied. The objectives of the 
present study were:
l. to establish a serum free, cytokine supplemented cD34* cell cultu¡e system 
to investigate
the role of various components of the haematopoietic microenvironment 
in supporting
megakaryocyticprogenitorcellsderivedfromcordbloodstemcells;
2. to characteri æ invitrothe differentiation of MK progenitor cells in 
liquid culture with or
without components of the extracellular matrix;
3. to establish the co-culture system with mouse bone mallow stromal 
cells (M-5) to study
the effects of cellular interactions in the differentiation of MKs; 
and
4. to assess the roles of adhesion molecules, such as integrins, and signalling 
molecules'







2.I.I ISOLATION OF MONOI\UCLEAR CELLS
(5%) Human albumin (NSA) cSL Parkville, Australia
Lypho prep Nycomed Pharma AS, Oslo, Norway
Red out Robbins Scientific, Sunnyvale, CA
USA
2.I.2ISOLATION OF CD34* PROGENITOR CELLS





MACS positive selection columns
Magnetic cell separator:
Precolumn separations 30 m filter
MACS, Miltenyi Biotec,
Gemany
human Ig FcR block reagent
monoclonal hapten-conj ugated
QBEND/I O.Isotype: mouse IgGl.
Microbeads conjugated to an anti-
hapten antibody.




MACS Miltenyi Biotec, GemanY
JJ
2,I.3 SEMI-SOLID AGAR CTILTTIRE MEDIT]M
(0.66%)Bacto-agar Difco, Michigan, USA
Fetal bovine serum (FBS) Trace Biosciences Pty Ltd, Castle
HilINSW Austalia
Mercaptoethanol AJAX Chemicals NSW, Australia
NaHCO3 AJAX Chemicals NSW, Austalia
2.1.4 LTQTID CULTIIRE MEDTUM
Stem ProrM 34 serum free medium
Horse senrm
Single strength Iscove's modified
Dulbecco's medium GvfDM)
GIBCO BRL, Life Technologies Inc.
GIBCO BRL, Life Technologies Inc.
GIBCO BRL, Life Technologies Inc.
GIBCO BRL, Life Technologies Inc
2.I.5 CYTOKINES FOR CULTT]RE
Recombinant Human Interleukin-3 (rhIL-3)
Recombinant Human Interleukin-6 (rhIL-6)
Recombinant human MegakaryocYte
Growttr Development Factor (rhMGDF)
Recombinant Human Stem Cell Factor (SCF)
Rabbit serum
Mouse senrm
2.I.6 ALKALII\E PHOSPIIATASE AI\TI.ALKALINE
PHOSPHATASE (APAAP) STAINING
R&D SYSTEMS Minneapolis, MN
USA
R&D SYSTEMS MinneaPolis, MN
USA
A gift from Amgen (Kew,Victoria),
Austalia






Mouse anti-human GpIIIa (CD6l)
Mouse anti-human IIB (CD4l)
Rabbit anti-mouse IgG antibodY
APAAP complex
Fast red TR salt











Mouse lgG2a (negative control)
Tetraspan Plt-(CDl5l)
Flow cytometry wash and fix reagents
















Gift of Dr. L. Ashman, Adelaide
University, Australia
(working solution 5Yoto block non-
CSL, Parkville, Australia
Coulter Electronics, Brookvale, NSW,
Ausüalia














lmmunoprecipitation kit (protein A)
ECL western blotting kit
Peroxidase-conjugated rabbit
Unconjugated monoclonal antibodies:
CD49d,CD49e, CD6l, CD53, CD63
2.I.IO BUFFERS AND SOLUTIONS






SYoin0.02 M Tris-HCl pH7,
Bio-Rad, USA
Bio-Rad, USA
BDH Chemicals Ltd. England
Kodak film
Boehringer Mannheim, Germany
Amersham Life Science, UK
DAKO Denmark
Immunotech, USA
137 mM NaCl, 2.7 rnNI KCl, 4.3mM
NazHPO¿, 1.4 mM KHzPO¿, pH7 .4
PBS PLUS O.O2% EDTA
One packet IMDM (Gibco), 390 ml
water injection, 1.5 ml DEAE-








Vy'estem blotting transfer buffer I
0.1M Tris buffer pH 8.2, 0.02 g,
Naphthol 2ml dimetþl formamide,
1 00¡rl (1M,0.24g) Levamisole.
work solution l:25 inO.l Tris-HCL
pH7.6.
25mM Tris-HCl, 0.192M gþine, PH8.3
0.3 M Tris-HCL, 20Yo }l,{ethalnol,
pH 10.4
0.025M Tris-HCl, 20% Methanol,
pH 10.4
0.025M Tris-HCl, 0.004 M,
aminohexanoic acid, 20YoMethanol, pH
9.4.
50 mM Tris-HCl, pH7.5,
150 mM NaCL
l% NP40, 0.5% sodium
deoxycholate.
one completerM tablet/ 25ml
50mM Tris-HCL, pH7,5,
500 mM NACL,
0. 1 % NP40, 0.05yo sosium deoxycholate.
50mM Tris-HCL, pH7.5,
0. 1% NP40, 0.05Yo sodium
deoxycholate.
Western blotting transfer bufer II
'Western blotting transfer buffer III
Immunoprecipitation kit (Protein A) buffer I
Immunoprecipitation kit (Protein A) bufler 2
Immunoprecipiøtion kit (Protein A) buffer 3
z.t.tt MISCELLANEOUS MATERTALS, CHEMTCALS
Cell count machine Performed on a Cell-Dyn 3500
10ml Falcon tubes Becton Dickinson, CA
24 wells Multidish Nwrclon A/S Denmark
Tissue culture dish (35x10 mm) Coming Lab. Sci' Co'
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A positive selection column was selected (size according to the number of tot¿l unseparated
cells) and placed in the magnetic field of the separator. The column was rinsed with buffer
(MS*/RS*, 0.5m1; VS*, 3ml). The cells were carefully passed through a 30pl filter to
remove clumps and applied to the column, and held in the column which rinsed with buffer
(MS*/RS* 4x0.5m1, VS* 4x3ml) to remove urbound cells.
CD34+ ce[s were collected by placement in a new tube. lml isolation bufler was loaded
onto the top of the column a¡rd the retained cells were eluted using the plunger supplied
with the column. The magnetic separation step was then repeated in order to achieve 60-
90Yo ofpurity of CD34* cells. Cells were gently washed 2x in StemProru 34 serum free
medium at room temperature.
2.2.4 MEAST]REMENT OF CD34* CELLS PTIRITY AI\D
RECOVERY
Flow cytometry was used to measure CD34 cell purity. lx10a isolated cells were directly
stained by 2.5¡Ã CD34-PE and CD45-FITC monoclonal antibodies, incubated for l5min on
ice and then washed once with Isoton II. At least 5000 events were acquired by flow
cytometry and analysed using the Lysis II software. Mouse IgGI-FITC and IgGl-PE were
used as isotype confols.
2.2.5 CELL COT]NT AIID VIABILITY
Manual count
For manual cell counts, blood samples or cells were mixed gentþ and 0.05m1were pipetted
into a plain tube, and 0.01m1 of toluidine blue (0.25% in PBS) was added and then mixed.
Cells were counted in 5mm2 of a hemocytometer. The number of cells (N)/mm3 : No. of
cell counted x 0.2 x l0 xl.2. (N was to be reported as x106ll).
Automated white cell counts were performed using a cell viability cor¡nt. Trypan blue dye
exclusion was used to determine cell viability. 0.2m1 cell suspension in medium was added
to 0.3m1 (0.4% w/v) trypan blue and 0.3m1 medium, mixed and allowed to stand 5-15min.
Cells were counted in 5mm2 of a Hemocytometer.
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Cell viability was calculated by the formula:
%viabîlity: number of viable cells ( total viable cells (unstained) xl00%o
total cells (stained and unstained)
2.2.6 CELLS CYTOSPIN
To 250p1 of the sample, 50¡ú 5% normal senrm albumin was added and centrifuged at 600
rpm, for 5 min in a Shandon Cytospin 3 cytofuge to prepare a cytospin sample. After air
drying, slides were stained in May Grunwald Geimsa.
2.2.7 MEGAKARYOCYTE COLONIY-FORMING IINIT (CFU-MIC)
Clonogenic progenitors, committed and relatively late progenitors with little self-renewal
potential, can be identified by the colony assay Semi-solid agar culttre. l-3x103 CD 34*
cells in l-lQpl StemProru34 serum free medium were added to each of 35mm petri dish.
The cells were added together with 0.5m1 medium (2.5x IMDM + 10% FCS) with the
appropriate cytokines. 0.5m1 agar (0.66%), liquefied in a microwave oven and cooled to
450C, and quickly but gently poured into each petri dish, mixed by swirling and spread
evenly over the surface of the petri dish to avoid any bubbles. Cultures were incubated at
370C in a fully humidified atmosphere of 5o/o COz for 12'14 days.
After 12-14 days, scoring of all colony types was performed with the 4x and lOx objective
lens to examine colonies in the petri dishes. The dishes were allowed to air drying at room
temperature, then stored at -200C prior to APAAP staining.
2.2.8 ALKALINE PHOSPHATASE ANTI.ALKALINE
PHOSPHATASE (APAAP)
MK lineage colonies were further identified by the APAAP immunostaining procedure.
This in situ technique utilises primary antibodies which directly bind to platelet
gþoprotein IIb/trIa (CD41) and IIIa (CD61) surface antigens which are commonly
expressed on platelets and their precursors. CFU-MK lineage colonies appear red and other
colonies appear blue.
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The colonies were fixed using 2ml of methanol: acetone (1:3) mixture for 20 min. Excess
fixative was aspirated and the dish washed twice with Tris-HCl buffer pH7.6.
Non-specific binding was blocked with rabbit serum (1:10 in dilution in Tris-HCl buffer pH
7.6) for 20 min. The dishes were then washed 4x with Tris-HCl buffer, pH7.6. The primary
antibodies CD41 (l:50 dilution with Tris-HCl buffer) and CD61 (l:100 dilution in Tris HCI
buffeÐ were added to the dishes, except to the negative control dish to which was added
mouse serum (l:5 dilution). The dishes were incubated for 30min, and washed 4x with
Tris-HCl buffer.
The secondary antibody, rabbit anti-mouse at l:25 dilution, was added to all the dishes
which were then incubated for 30 min and washed 4x with Tris-HCl buffer. 0.5 ml of
mouse APAAP reagent (1:25 dilution) was added to the dishes and incubated for another 30
min, and washed 4x with buffer.
The filtered substrate solution 0.5m1 was then added and incubated for 20 min and then
washed 2x with buffer. Following counterstaining for 5 min in Evans Blue, excess was
gently rinsed off with distilled water and the plates were allowed to air dry. Plates were
mounted with aqueous warmed gþergel medium and examined for colony formation.
Three categories of MK colonies were identified in the agar culture:
CFU-MK - pure megakaryocyte colonies. CFU-MK ranging in size from 3 to several
hr¡ndred MKs per colony.
CX'U-Mkmix - mixed MK colonies (containing other lineages in addition to MK).
NON MK - non megakaryocyte colonies. They were usually granulocyte and monocyte
lineages.
MK and platelets which express gþoprotein trb/IIIa (CD4l) and IIIa (CD6l) appeared
pink following fixation and staining. Cor¡nterstaining with Evans blue caused the nuclei of
all cells to appear pale blue regardless of lineage.
Because CFU-MK ranged in size from 3 to l00s of MKs per colony, it was convenient to
subdivide them by colony size:
oSmall colonies 3-20 cells/colony.
oMedium colonies 2l-49 cells/colony.
olarge colonies 50-over I O0cells/colony.
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2.2.9 CELL CULTT]RE
The growth of megakaryocytic progenitor cells derived from CB CD34* cells were cultured
using three different culture conditions.
1. Liquid cultr¡re. A Stem Proru 34 serum free medium was used as a basic culture medium
with IL-3, lL-6 (20nglm1), SCF (50ng/m1) 
*l- tucor (sOng/ml) cytokines.
2. Fibronectin cultr¡re. Lyophilised human fibronectin was dissolved in sterile distilled
water to a final concentration of lmg/ml. 0.25 ml of this solution was used to coat each well
(24 wells/plate). The wells were refilled with StemProru34 free medium with cytokines.
3. Stromal culflre. Mouse stromal celts (MS-5) were a gift from Dr. Inoue Hideo. The cells
were cultued in IMDM, supplemented with 10% horse serum, and penicillin-streptomycin
(Coulombel et al., 19S3). lml aliquot of the suspension containing 1x10ó stomal cells
were plated in a2icmflask, and placed in an incubator and cultured at 370C, 5Yo COz and
90% humidþ. Cells were fed every 7 days by replacing50% of the supernatant with fresh
medium. A confluent layer of stomal cells formed in2'4 weeks.
Sfomal cells were washed ¡vicewith PBS detached by treatment with 0.05% trypsin
solution for 5min and resuspended in Stem Proru 34 serum free medium with cytokines, I
x10a cells were distributed into 24 wells plates, until the stromal cell confluence was
reached in 2 days.
purified CD34* cells were seeded at a concentration of 2xl04lml in 24-well tissue culture
plates at I ml Stem-ProrM 34 serum free medium with cytokine per well. The cultures were
incubated at370C in a fully humidified atmosphere containing 5%o COz up to 4 and 8 days.
After 4 days and 8 days cells were gently mixed, collected and processed as follows:
. an aliquot cell cor¡nt performed on the automatic Cell-Dyn 3500 machine or manually,
depending on the cell numbers.
o a 100 -200 pl aliquot for cytospin to assay cells differentiation and morphology.
. an aliquot to monitor the megakaryocytic progenitor cells:
l.CFU-MK as¡say
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2. Imm¡nophenoteping for MK differentiation using immunoflourescence flow cytometry
2.2.10 FOR IMMT]NOPHENOTYPING USING FLOW CYTOMETRY
SET CONTROL
The control was always a monoclonal antibody using in the experiment and same subclass.
2.5 ¡tl isotype matched lgGltlgG2 monoclonal antibodies were used. This control help
recognitive the stained cells considered to be positive.
DIRECT STAINIG
lxlgó/ml cells were blocked by Intragam and incubated at 220c,30min 2.5 ¡i of the
monoclonal antibodies were added to each tube and incubated l5min, 40C in the dark. Cells
were washed once with 2ml of Isoton II and l% NSA at 3009 centrifuge for lmin. After
vortex, the cells were fixed in 0.3 ml of lYo panformaldehyde in Isoton II. The cells were
kept at 40C in the dark and analysed within 24hr on the FACScan using Lysis II software
(Becton Dickinson).
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SUMMARY OF CELLS ST]RFACE MARIGRS
Surface ma¡kers used a¡e listed in Table 2'l'







very early antiger¡ for stem cells
very late antigen (VI-44)




























2.2.II FLOW CYTOMETRY ANALYSß
Frow cytometic analysis was performed on a FACScan @ecton-Dickinsin). 
A range of
5000-10,000 cells was collected in list mode format using B 
D LYSIS II softwa¡e'
2.2.12 GATING STRATEGY
Dead cells were gated out by TAAD staining and the percentage 
of cells positive for various
markers was determined ûom tlre total live population' Then 
a gating from TAADÆSC
was used to determine the cells within a FSC/SSC (forward scatter/side 
scatter ligbÐ
l¡rmphocytes gate Rl, Fig.2.1.4. The combination cells from gate Rl 
were further analysed
for R2 CD34 positive (CD34)' and cells in region R3 was CD34 
negative (34'Fis'2'l'B'
The brigbt cD34* ceils and negative cD34- cells were anarysed 
for positive staining other
markers. pain¡,ise combinations of fluorescently rabelled monoclonal 
antibodies against
the integrins (cD19d, cD49e, CD61) and the three tetraspans 
(cD53, CD63, CDl5l) were
used to determine the co-expression of the respective integ¡in/tetraspan 
pairs'
2.2.13 IMMI]NOPRE CIPITATION
In this study, we further determined association of the respective 
integrins and tetraspans
complexes on the cell surface by immunoprecipitation' Following 
liquid culture' the
cD34+ ce[s (2xloalper welr) were groriln with or without 
fibronectin for 4 days. 1x106-
rox106/d ceils were colrected and washed once $'ith 
pBS buffer and centifuged 18769, 10
min. (Samples were generally prepared according to the Protein 
A Immunoprecipitation Kit
Boehringer-Mannheim package insert). Briefly, the cell pellet 
was suspended in lysis
buffer, cells were frozen on dry ice for lgmin then thawed at37oC 
for lgmin' This process
was repeated 3 times. The suspension was cenÍifuged at 
120009, l0 min, 40C to remove
debris. After tansfer of the supernatant to a Eppendorf 1'5ml 
microfuge tube' each lml of
solution was pre-cleared by the addition of 50 pl of homogeneous 
protein A-agarose' and
incubated ovemigbt at 4oC with rocking. The agarose was removed 
by centrifugation at
12,0009 for 20 seconds in an Eppendorf microfuge. 0.2tg of the 
appropriate purified
monoclonal antibody against cD4gd,cD49e and cD61 was 






























FIG. 2.1 Gating strategy. A:(Rl) backing from TAAD/FSC to a
FSC/SSC lymphocytes gate. B: a backing gate from Rl of
FL3/SSC to a CD34+ cells gate (R2) and aCD34- cells gate (R3).
0
RZ =ül]l-¡ sft
H3 = ül]l- r*
and incubated at 40C for thr with roeking. Homogeneous protein agarose (50p1) was added
to each sample, incubated at 40C for a further 24hr with rocking. The pellet, which
contained the integrins -protein A complexes, was washed once in 1 ml buffer I (Protein A
kit) and incubated at 40C for 20 min on a rocking platform. The process was repeated once
with the same wash buffer 1. To the collected complexes was added 1 ml of wash buffer 2
þrotein A kiÐ. Complexes were resuspended, and incubated at 4oC for 20min on a rocking
platform. Beads were again pelleted and the supernatant removed. The pellet was
resuspended in lml of wash buffer 3 þrotein A kiÐ and incubated for 20 min at 40C on a
rocking plaform. The respective pellet, which contained the CD49d, CD49e, and CD6l-
antibody-protein-A complexes, wð then resuspended in 40pl gelJoading buffer (l% wlv)
sDS, (l0o/o øÐ, 0.02 M Tris-HCl pH 7, 2-mercaptoethanol (5%), 0.1% (ilÐ
Bromophenol Blue. Samples were boiled for 5 min, centrifuged at 12,0009 for 20 sec at
room temperature and supernatant was transfer to a fresh tube. Samples were analysed by
SDS-PAGE and Westem Blotting.
Protein samples were separated on a mini SDS-PAGE gel conøining lÙVo polyacrylamide
and transferred onto Hybond-C nitrocellulose using the semi-dry electroblottet at 64 mA for
2 h. The membrane was blocked with 5% skim milk at room temperature for 2 h, the
membrane was washed 3 times in PBS containing l% (wlv) BSA and 0.1% Tween 20 and
then incubated ovemight with l0ml of a 1:500 dilution in PBS of tetraspan monoclonal
antibodies (CD63 or CD151) at 40C with rocking. After washing with PBS buffer 3 times,
the membrane was incubated \¡rith HRP-conjugated mouse anti-IgG (1:10000 ) in PBS for
lhr at room temperature with rocking. The blot was washed 1x15 min and 4x5 min in fresh
changes of buffer. The membrane was exposed in equal volume of l0 ml of detection
solutions I and 2 atl min, the excess solution was poured offand the membrane which was
then wrapped in Cling-Wrap and exposed to a X-ray film in a light-tight cassette. The
exposure time varied from I min to 30 min, depending on the amount of target protein
applied in the membrane.
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2.2.14 STATISTICAL ANALYSIS
The data were expressed as meantstanda¡d error of the mean (SD). Statistical analysis was
performed using a non-parametic Mann-Whitney U Test. The values of P<0.05 were





3.1 THE ROLE OF MGDF IN MEGAKARYOCYTE
PROGENITOR CELL DEVELOPMENT IN
IN WTRO CULTU
INTRODUCTION
Regulation of megakaryopoiesis is controlled by a complex series of interacting cytokines
in vitro. MGDF was shown to induce thrombocytosis frt vivo arrd stimulate MK colony
formation as well as MK maturation invitro (de Sauvage et al, 1994)- MGDF is thought to
be the major regulator of megakaryopoiesis.
Megakaryocyte development is possibly the net effect of interactions of CD34+ precursors
with extracellula¡ matrix and secreted cytokines in particutarly MGDF. The mechanism by
which MGDF regulates megakaryocyte development is not well defined. This study
investigates the possible interactive mechanisms of MGDF and extracellula¡ matrix in
megakaryopoiesis bY:
(l) examining the effects of MGDF on cD34+ cell proliferation;
(2) analysing changes in the expression of adhesion molecule receptots CD49d and CD49e
on MK lineage in the presence of MGDF;
(3) determining the functional role of integrins CD49d and CD49e in megakaryopoiesis in
the presence of MGDF and/or fibronectin and/or stromal cells.
Isolated cD34* cells from cB were used as the starting cells.
3.1.1 ßOLATION OF T]MBILICAL CORD BLOOD
cD34 POSTTTVE CELLS (CD34)
0.1%-0.5% of CB cells are CD34*. Immunomagnetic separation with the MACS system
increased the proportion of CD34* progenitor cells in the CB to over 90%. Non-separated
and isolated cD34* cells were analysed by flow cytometry. cD34* cells were gated' A
t¡.pical dot plot and histogram of pre and post isolation CD34+ cells directly labelled with
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cD34-pE and CD45-FITC is shown in Fig 3.1.1. In the example 0.17% of unseparated
CD45CD34* cells and 94Yo of MACS system isolated cells stained with CD34-PE. The
enrichment of CD34 positive cells was 55-fo1d from mononuclear cells, and 188-fold from
whole CB
The degree of enrichment of CD34* cells in the 77 individual cord blood samples used in
this study ranged from 60% to 98Yo but was generally in the range 85%-98% (Table 3 . 1 . 1).
As expected the isolated CD34* progenitor cells were morphologically a relatively
homogenous population of large cells with little evidence of cytoplasmic matr¡ration Fie'
3.1.2.
3.I.2 THE EFFECT OF MGDF ON TOTAL CELL COT]NT IN
LIQUID CT]LTTIRE
The effect of MGDF on CD34* proliferation in tiquid culture with standard cytokines (SCF'
IL-3 and IL-6) was assessed at day 4 and 8 of cultwe. The total white cell count was
performed. As shown in table 3.1.2. MGDF with standard cytokines has minimal effective
support for CD34+ cell proliferation at day 4 and 8. V/ith or without MGDF there was a
9.5-10 fold increase by day 4, andan increase of 38-49 fold cells over starting cell number
(2x104/ml) by day 8.
3.1.3 TIIE EFFECT OF CYTOKII\ES ON CFI]-MK
IN AGAR CT]LTT]RE
lxl03 cD34* cells were incubated with MGDF alone or with individual cytokines SCF' IL-
3, n -6, and with combinations of cytokines to determine the effects on MK colony
formation. The effect of cytokines on the nunrber of CFU-MKs is shown in Fie. 3.1.3
MGDF alone produced GFU-MK colonies. However, MGDF and IL-3 or IL-6 produced
less colonies than MGDF alone. The three cytokines, scF, IL-3, and IL-6 in combination,
supported CFU-MK growth better than the two cytokine combination including MGDF
alone. The combination of all cytokines stimulated the greatest increase in the CFU-MK
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FIG.3.l.l. FACS analysis of mononuclear cells from cord blood using MACS CD34
isolation kit. Using direct staining with CD34-PE (vertical) and FITC-CD45
(horizontal axis). Rl (region 1) and marker Ml define CD34* cells from
mononuclear cells of the cord blood (Ð, MACS purified and isolated cD34*





Table 3.1.1. Percentage of CD34 positive cells. Table shows the percentage of MACS
pr:rified CD34+ progenitor cells by histogram analysis.





















FIG. 3.1.2 Stained CD34* cell progenitor cells. The CD34* progenitor
cells were cytofuged and further assessed by Wright-Giemsa
staining. Original magnification x120.
Table. 3.7.28trect of MGDF on cell count in liquid culture.
Viable cell count (1x106/ml)




































0 control 5+3+6 M+S+3+6 M+SCF M+3 M+6 MGDF
FIG. 3.1.3. Effects of cytokines on CFU-MK colony number. CD34* cells were
cultured in semi-solid agar within different cytokines for 2l days.
The results shown as the mean tSD (n:3). M:MGDF, S:SCF, 3:IL3,6:1L6.
Control was medium alone.
*p:0.043 significantly different compared \Mith (M+S+3 +6).
* r'p<O. 0 I 4 significantly different compared with (M+S+3 +6).
*'r *p<0. 0 1 I significantly different compared with (M+S+3 +6).
3.2 DETECTION OF ADHESION AND TETRASPAN
MOLECULES ON CD34+ CELLS
Little is known about the expression and functional role of adhesion molecules of the
integrin p1 family and the tetraspan superfamily on megakaryopoiesis. The percentage of
CD34* cells expressing several of the integrins (CD49b, CD49d, CD49e, CDl8, CDlla"
CD4IU CD5l, and CD6l), and tetaspans (CD53, CD63, CD9) was determined. Results
of their expression are shown in Table 3.2.1. In the integrin family, expression of CD49d
positive CD34cells was the higbest (94.0%+1.8) and CD49e positive CD34 cells the lowest
(5.4%t3.8). The percentage of expression of the other integrins was: CD6l (39.Oo/o!3-7),
cD4la (32.3o/o_5.l), cDlla (93.8o/ot3.9), CDIS (73.3%t5.1), CD51 (27.3t2.1) and
CD49b (39.313.3). In the tetaspan family, 21.1/s+1.2 of CD34+ cells expressed CD63
whereas CD34+ cells expressed low levels of CD9, CD53 and CD151 (3'5'6'5%)'
3.2.I EXPRESSION OF CD49D AND CD49E ON CD34* CELLS
CTILTTIRED }VITH OR }VITHOUT MGDF
CD34* cells were cultured in liquid culture with standard cytokines with or without MGDF
over 8 days. The expression of CD49d and CD49e was evaluated Fig 3.2.1. Majority
(g45yù of CD34* cells expressed CD49d at day 0 in both culture conditions, the
percentage of expression of CD49d was significantly reduced at day a fpa.grt) to the
same extent but was increased at day 8 (p:0.021) inespective of the addition of MGDF.
.However, at day 8 there wrrs a slightly higher percentage of CD34* cells expressing CD49d
with MGDF than without MGDF (73.5% vs 66-9Yo, p>0.05).
By contast to CD49d, only a small percentage (5.4W of cells expressed CD49e at day 0
and the expression of CD49e deøeased further irrespective of the addition of MGDF at day
4 Fíg. 3.2.2. However, the percentage of CD49e positive cells was significantly increased
by day 8. Also at day 8, the addition of MGDF increased the percentage of CD49e on
CD34* cells significantly compared to those cultured in the absence of MGDF (22Yo vs
l2Yo,p:0.02).
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Table 3.2 I Expression of integrin and trtraspan molecules on CD34* cells at day 0
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Day 0 Day 4 Day I
FIG. 3.2.1. Expression of CD49d and CD49e on CD34* cells following
culture with or without MGDF during day 0 to day 8. Each value represents
the mean +SD (n=4).
*p:0.021 significantly reduce compared with day 0.
**p:0.021 significantly increase compared with day 4.












3.2.2 THE EFFECTS OF MGDF ON EXPRESSION OF
MEGAKARYOCYTIC Lil\¡'EAGE MARKER CD61
CD6l belongs to the p3 integrin superfarnily and is a specific lineage marker of MKs and
platelets and also on macrophage and endothelia cells. Lineage can be assessed by flow
cytomeûry using expression of CD6l. CD34* cells were cultured with standard cytokines in
the presence or absence of MGDF in liquid cultr¡re for up to 8 days. The results are
summa¡ised in Fig 3.2.2 (D. Expression of CD6l on CD34* cells was 39o/o+3.3 at day 0-
'With culture there was a significant reduction of expression of CD6l by day 4 (IF0.02).
However, MGDF maintained a slightþ higher percentage of expression CD61 on CD34+
cells, (9.0olo 10.5 vs 7.5%t1.2). At day 8, CD61 expression increased further with MGDF
maintaining a significantly higher percentage of expression (p--0.043). CD61 expression on
day 4 and day 8, however, remained lower than that of day 0 (F0.021).
The expression of CD6l on CD34- cells was investigated in culture presence and absence of
MGDF over 8 days incubation, W3.2.2 Gi\. The initial expression of CD6l on CD34-
was low (12%10.2) at day 0, \¡vith over 90%o of cells being CD34* at day 0. Similarly to
CD34* cells at day 4, there was significant reduction of expression of CD61 (IF0.02)
compared with day 0 levels, in both presence and absence of MGDF. However by day 8,
CD6l levels had risen to 24o/oß.1 at day 8 and to l9o/o12.3 in the presence and absence of



































FIG.3.2.2. The effects of MGDF on expression of CD6l lineage
marker on CD34+ cells and CD34- cells in liquid culture at day 0
to day 8. The data are expressed as the mean tSD (n:3).
P:0.02 significantly decrease compared with day 0.
*p:0.043 significantly increased compared to culture without
MGDF at day 8.
**p:0.043 significantly increased compared to day 0 on CD34- cells.
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3.3 EFF'ECT OF F'IBRONECTIN ON MEGAKARYOCYTE
DIFFERENTIATION
INTRODUCTION
The effect of fibronectin on the development of MK progenitor cells was investigated by Ð
the expression of MK lineage markers CD61 and CD4la" iÐ MK progenitor colony assay
following subculture and iii) co-expr-ession of Þr integrins and tetraspans in the presence of
fibronectin.
3.3.1 EFFECT OF F'IBROI\ECTIN ON CD34+ CELL NT]MBER
AI\D PERCENTAGE OF CD34* CELLS IN CT]LTT]RE
The effect of addition of fibronectin to cell culture on total and CD34* cell number is
shown in Table 3.3.1. At day 4 in liquid culture, the total cell number was increased 4.4
fold over day 0 and in the presence of fibronectin 6.8 fold. Assuming 90Yo of cell on day 0
were CD34* cells, the number of CD34* cells was increased 1.5 fold in liquid culture and
2.0 fold in fibronectin over day 0 levels. By day 8, ttrere were further significant increases
in both tot¿l cell and CD34* cell cowrts in both liquid and fibronectin cultures. However,
the rise in both these counts at both days 4 and day 8, was significantly greater in the
presence of fibronectin than in liquid culture alone GF0.021). At day 8, fibronectin culture
showed increase in total cell number of 15 fold and in CD34+ ceil number of 2.9 fold.
The percentage of CD34* cells was investigated in both cultures at day 0, 4, 8. In the
example given in Fiq. 3.3.1 760/o of ce\ls at day 0 were CD34*. By day 4,the percentage of
CD34+ cell had decreased to 65Yo in fibronectin culture and even furtlrer (50olo) in liquid
culture. By day 8, the percentage of CD34* cells was reduced to l4.5Yo in fibronectin
culture andS.4voin liquid culture. CD34* cell numbers in liquid versus fibronectin cultures
were significant different (p:0.02). Fibronectin may have the potential to increase CD34+
cell number. ECM may have a "secret preserver" of CD34* cells during cell cultr¡re.
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Table 3.3.1 Effect of fibronectin on CD34+ cell number during cell culture
Total cell nurnber (xI04) CD34+ cell number (x10a)
Day 0 Day 4 Day 8 Day 0 Day 4 DaY I
LI 2.0 8.816.7 12.2.+8.9 1.8 2.8+1.8 3.2+2.6
FIN 2.0 13.9+7.9 r,3g.Q+10.1 1.8 3.6+1.7 5.3+3.6
Data represent meantsD (n:4). LI: liquid culture, FIN: fibronectin culture.










































FIG. 3.3.1. The effect of fibronectin on proportion of CD34* and CD34- cells from day 0



































3.3.2 IVTICROSCOPIC STT]DY OF CD34+ CELLS
CTTLTT]RED ON FIBROIIECTIN
A typical photomicrogaph of cell growth with or without fibronectin is shown in Fig. 3.3.2.
In the presence of fibronectin, cells were frequently seen clustered around fibronectin
fibres, whereas in liquid culture, colony-like clusters of cells were seen'
3.3.3 TITE EFFECT OF FIBRONECTIN ON MK PROGEI\üTOR
CELL GEI\ERATION USING IMMTINOPHENOTYPING
At day 0, cD34+ cell co-expression of cD61 (Gpllla<arly marker) and cDlla (Gptrb-
intermediate marker) was 39Yo and 32% respectively Table 3.2.1. Both lineage markers
altered expression on CD34+ and CD34- cells during culture. Furthermore, CD6l has been
detected on endothlial cells, monocytes, and fibroblasts, as well as megakaryocytes @ai et
a1., 1984), CD61 is a sensitive, but not specific marker for the megakaryocytic lineage
Fig. 3.3.3 shows the effect of fibronectin on co-expression of MK lineage markers CD61
and CD4la on CD34* cells at days 4 and 8. In the presence of fibronectin, CD34* cells
significantly increased expression of CD6l (IF0.043) and CD4la (IF0.021) compared with
liquid culture at day 4. At day 8, the percentage of CD34* cells with co-expression of
CD61 was significantly increased in the presence of fibronectin (IF0.021) but there was no
significant difference in expression of CD41a between the two culture systems. fn fact
there was a decrease in expression of CD4la on CD34* cells in the presence of fibronectin
at day 8.
Figure 3.3.4 shows the expression of CD61 and CD4la on CD34- cells in both culture
systems at day 4 andday 8. Both CD6l and CD4la expression were significantly higher on
CD34- cells, a 5.7 fold increase in percentage expression of CD6l and a 3.5 fold higher
expression of cD41 were noted in the presence of fibronectin at day 4 (p:0.02t). At day 8,
in the presence of fibronectin, the percentage of expression of both CD61 and CD4la on
CD34* cells was significantþ higher (IF0.043) than CD34- cells in liquid culture. Taken















FIG. 3.3.2 A photomicro$aph of the cD34* cells cultured without
fibronectin (A), or with fibronectin (B). In the presence of fibronectin,
cD34* cells were seen clustered around fibres (indicated by a:row).
Original magnification x2 5 0.

















cD61 CD¿tla cD61 CD41a
FIG. 3.3.3. The effects of fibronectin on expression of MK lineage markers
on CD34* cells. Expression of CD6l results are as the mean+SD (n:4).
*p:0.043 significantly increased compared with liquid culture.
**p:0.020 significantly increased compared with liquid culture.
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Day 4 Day I
FIG. 3.3.4. The effects of fibronectin on CD34- cell xpression of MK markers
during culture period.
The results are shown as the meantSD (n:4).
* p: 0.021 significantly increased compared with liquid culture at day 4.
**p:0.043 significantly increased compared with liquid culture at day 8.
3.3.4 EFFECT OF FIBRONECTIN ON MK PROGEMTOR
CELL GEI\ERATION
At day 4 and 8 of culture, cells were subculû¡red into semi-solid agar for CFU-MK colony
assay. CFU-MK colony numbers were increased in the presence of fibronectin but, the
increase was not statistically significant @:0.08) at day 4 Fig.3.3.5. However, at day 8 the
number of CFU-MK colonies was significantly increased in the presence of fibronectin
CF-0.029). The CFU-MK results indicated ttrat fibronectin increases commiÍnent of
precursor cells to the megakaryocytic lineage.
3.3.5 EFFECT OF FIBRONECTIN ON MK PROLIFERATION
The effect of fibronectin on proliferation of MK progenitors was assessed by examination
of three individual experiments on MK colony size (number of cells per colony) in semi-
solid agar culture. The size of CFU-MKs was slightþ increased in the presence of
fibronectin, the liquid culture showed a slight bias to the smaller (1-5 cell) colonies (2lYo of
total colony CFU-MKs vs l0% for fibronectin) whereas fibronectin showed a slight bias to
larger (>100 cell) colonies (29Yo of total colony CFU-MKs vsZlYo for liquid) Table 3.3-2.
These data suggest that fibronectin has some effect on proliferation of differentiating MK
progenitor cells.
3.3.6 THE EFFECT OF FIBRONECTIN ON EXPRESSION OF
INTEGRINS AI\TD TETRASPAI\IS ON CD34* CELLS
The mechanisms by which fibronectin increases megakaryocyte commitment were studied
by assessing its effect on integrin and tetraspan expression and their molecular interaction.
CD34* cells do not constitutively express CD49d and CD49e integrins. with culture
CD34* cells increased their expression of these two integrins. The effect of fibronectin on






















day 4 day 8
FIG. 3.3.5. The effect of fibronectin on MK lineage commitment. CD34* cells were
co-cultured with or without fibronectin for 8 days. On day 4 and day 8, cells were
subcultured in semi-solid agar for a further 14 days to identifu CFU-MK. The results
are shown as the meantSD (n:3).
*P:0.043 significantly increased compared with liquid culture.
** p- 0.029 significantly increased compared with liquid culture.
Table. 3.3.2. Effect of fibronectin on MK colony size at day 4
Total colony
(No.)
Range of colony size on day 4 (cell no.)











CD34+ cells (lxl0a/ml; *ere cultured in the presence of fibronectin or liquid culture. At day
4, 1x103/ml cells were further subcultured in semi-solid agar for 14 days. Data represent
values from three independent experiments.
There was no significant difference on MK colony size in either cell culture system.
summarised in Table 3.3.3, and representative dot plot of CD34+ cell expression of CD49d
and cD49e at days 4 and 8 of cell culture Fig.3.3.6 and Fie. 3.3.7.
A significantþ higher expression of cD49d and cD49e (IF0.043) was noted in the
presence of fibronectin compared to liquid culture by day 4. At day 8, CD34* cells
increased their expression of CDtgd with a higher percentage of cells expressing it in the
presence of fibronectin (p0.0a). A signifrcant increase in expression of CD49e (IF0.021)
was also noted in the presence of fibronectin compared to liquid culture'
When the more diflerentiated CD34- cells were studied, it was similarly found that by day 4
fibronectin resulted in an increase in expression of CD49d and CD49e (p=0.02). However,
the expression was less than that observed with CD34* cells Table 3'3 3'
By day B, CD34- cells increased further their expression of CD49d \¡/ith a higber percentage
of cells expressing it in the presence of fibronectin (IF0.043). The expression of CD49e
was similarly increased on CD34- cells by fibronectin. However, the CD49d expression on
CD34- cells was as high as that of CD34* cells at this time point (97.9o/o YS 96.8%
respectively). These results suggest that fibronectin maintained and enhanced expression of
CD4gdand CD49e on CD34* cells.
Tetraspan molecules a¡e associated \¡vith integrins and are considered to be important in
signal transduction for the integrins (Schwartz et al, 1995). There are several candidate
tetraspan molecules and preliminary experiments showed a co-expression of CD63 and
CDl5l $rith CD49d and CD49e on CD34* cells. Furtherrrore, CDl5l was found on
megakaryocytes and platelets but its role in megakaryopoiesis is unknown. Therefore the
effect of fibronectin on expression of the tetraspans CD63 and CD151 was investigated.
The results are shown in Fig. 3.3.8. At day 0, cD34* cells co-expression of CD63 was
2l.l%+ 1.2. There vras a 75o/o-85Yoof CD34+ and CD34- cells co-expressed CD63 in both
cultures atday4. Expression of CD63 was Similarly obtained in both cell cultr:res at day 8.
However, as with day 4,the percentage expression of CD63 was not altered by fibronectin
at day 8.
The effect of fibronectin on expression of CDl5l can be seen in Fig.3.3.8. CD34+ cells
have a low expression of CD15l at day 0, but by day 4 fibronectin increased slightly the
expression of CDl5l on CD34+ and CD34- cells. The percentage expression of CDl51 was
higher on CD34- cells in bottr cultures. However, fibronectin significantly increased
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Table 3.3.3 The effect of fibronectin on expression of integrins on CD34* and CD34-cells.
Day 4



















The results show expression level as the mean + SD (n:3). FlN:fibronectin, Ll:liquid.
* p:0.043 significantly different from liquid culture.
**p:0.043 significantly different from liquid culture.



























































FLl-H\CD49E FITC-r FL1-H\CD{9E FITC-r
FIG.3.3 6. Representative dot plots showing the effect of fibronectin on CD34+
cell co-expression of CD49d and CD49e at day 4. LI. control : <lYo positive
events of liquid on control plot (a). FIN control : <l%o positive events of
















































































Fl l-HlGamma-l Cnnlrnl FIT(Ì- FLI -H\Gamma-l Contro¡ F¡TC-
1
Fl 1-HlCn¡lllD FITC-' FLl-HïCD49D FITC->
t
FLl-H\CD4SE F|TC-> FLr-H\CD4gE F|TC->
FIG. 3.3.7. Representative dot plots showing the effect of fibronectin on



































































FIG. 3.3.8. Effect of fibronectin on expression of tetraspans on CD34+
and CD34'cells during cell culture over 8 days. The results were shown as
the meantsD (n:3). There was no significantly different in CD63
eipression on CD34* or CD34- cells using either culture system. The
percentage expression of CD15l was significantly increased on CD34* and
CD34- cells in the presence of fibronectin at day 8.
Ll:liquid, FlN:fibronectin.
*p:0.021 significantly different from liquid culture.
expression of CD151 at døy 8 on both CD34* and CD34- cells (p:0.02). These results
indicate that fibronectin has little influence on the expression of CD63 on CD34* and
CD34- cells in contrast to the expression of CD15l'
3.3.7 THÍ' EFFECT OF FIBRONECTIN ON INTEGRIN
AI\D TETRASPA}I CO.EXPRESSION
To define the relationship of the tetaspans with the integrins, CD34* cell co-expression of
integrins CD49d, CD49e and CD 61 (MK marker) with tetraspans CD63 and CD 151 was
determined.
At day 0, there was no co-expression of CD49d, CD49e and CD6l with CD63 on CD34+
cells. However, culture of the cells led to an increase in their co-expression on both CD34*
and CD34- cells.
cD34* cell co-expression of integrins cD49d, cD49e and cD6l (MK marker) with
tefraspan CD63 was analysed by contour plots Table 3.3.4 and representative contour plot
in Fig.3.3.9.
At day 4, co-expression of CD49d/CD63 on CD34* cells in fibronectin was significantly
higher than on these cells in liquid (control) culture (p:0.043). However, the presence of
fibronectin resulted in reduced co-expression of CD4gelCDó3 and significantly reduced co-
expression of CD61/CD63 (IF0.043) on these cells at day 4'
At day 8 on CD34*cells the presence of hbronectin resulted in a slightþ greater co-
expression of CD49d/CD63, and a significantþ (IF0.021) higher co-expression of
cD4ge/cD63 and CD6llcD63 compared with liquid cultr¡re contol representative contour
plot in Fig.3.3.10.
When day 4 and 8 fibronectin cultures were compared, it was found that there was
increased co-expression of cD49d/cD63 (91.8% vs 60.9yo), cD49elCD63 (61'8%
vsl2.1%)and CD61/CD63 (37. Yovs7.SW on CD34* cells at day 8. 
'When 
day 4 and day 8
liquid culture were compared, there was an increase co-expression of CD49dlCD63 (71'9o/o
vs36.9þ on the CD34* cells on day 8 ari compared to day 4. However, the percentage co-
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Table 3.3.4. Co-expression of inægrins on CD34* cell CD49d, CD49e and CD61
(MK marker) with tefraspan (CD63) at day 4 and day 8 of cell culhre.
DAY 4























The data was obtained from analysis of contorx plots. Results expressed
as the meantsD (n:3). LI: liquid culture, FIN: fibronectin culture.
* p:0.043 signifrcantly diflerent compared with liquid cult¡¡¡e.
**p:0.021 signifrcantþ different compared with liquid culture.




































































































1 t FLI-H\CD61 FITC->FL1-H\CD61 FITC_>
FIG. 3.3.9. Contour plots showing the effects of fibronectin on
co-expression of CD4 9 dl CD63, CD 49 e I CD63 and CD6 I /CD63
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FLI-H\CDEI FITC-> FLI-H\CD6I FITC_}
FIG. 3.3.10. Contour plots showing the effects of fibronectin on
co-expression of CD4 9d/ CD63, CD49el CD63 and CD6 I /CD63











expression of CD49elCD63 and CD6I/CD63 was significantþ decreased in the liquid
culh¡re at day 8.
CD34- cells also showed co-expression of CD49d, CD49e and CD61 with CD63. The
result was shown in Table 3.3.5 and representative contour plot Fig.3.3.11 and 3.3.12.
At day 4, the data showed tlrat co-expression of CD49d/CD63 on CD34- cells in the
presence of fibronectin was signifrcantþ increased (p:0.043) but the presence of
fibronectin resulted in a decreased co-expression of CD49elCD63 and no change of
CD6llCD63 at daY 4.
However, at day 8, the presence of fibronectin resulted in a slight increase in co-expression
of cD4gdlcD63 on cD34- cells and a significant (IF0.043) increase in co-expression of
cD4gelcD63 (3g.g%vs 15.1%o) and cD61/CD63 (4t.4% vs 16.5%) as compared to liquid
culture at day 8.
Furthermore, on cD34' cell, when day 4 and day 8 fibronectin cultures were compared,
there were significantly (p:O.O+¡) increase co-expressions of CD49ü/CD63 (80-5% +6.9 vs
44.1o/o!8.9),) CD49elCD63 (39.8%o+6.8 vs l3.lo/o!2.7) and CD61/CD63 (41.4%t5.5 vs
23.4o/ol7.l) on CD34- cells at day 8 as compared with day 4'
When day 4 and 8 liquid cell culture were compared, co-expression of CD49ú/CD63 was
increased (65.7%L4.6vs27.0Yo+6.0). However,CD4ge/CD63 (15.1%+7.5 vs 19.4%+5'1)
and CD61/CD63 (16.5%t5.2 vs 23.4+8.4yo) were decreased at day 8 on cD34- cells as
compared with day 4.
Taken together, these results suggest that fibronectin may play an important upregulatory
role for integrin and tetaspan co-expression on both CD34* and CD34- cells. Furthermore,
fibronectin may be responsible for co-expression of CD49d/CD63 at an early rather than
late stage. However, the effect of fibronectin on co-expression of CD49elCD63 and
CD6I/CD63 were mostþ atalate stage of cell growth'
As shown in Fig. 3.3.13, the effects of fibronectin on co-expression of CD49d, CD49e and
CD6l respectively with tetraspan CDl5l were investigated at days 4 and 8. The percentage
co-expression of CD49d, CD49e and CD6l with CDl5l was not significantþ increased at
day 0 (datanot shown).
At day 4 on CD34* cells, co-expression of CD61/CD151 was significantly increased
GF0.043) in the presence of fibronectin as compared with liquid 
culture. However, in both
57
Table 3.3.5. Co-expression of integrins on CD34- cells CD49d, CD49e and CD6l (MK
marker) with tetaspan (CD63) at day 4 and day 8 of cell culture.
DAY 4























The data were obt¿ined from analysis contor¡r plots. Results expressed as the
mean +SD (n:3). LI: liquid culture, FIN: fibronectin cultr¡re.








































































































FIG. 3.3.1l. Contour plots showing the eflect of fibronectin on co-expression
of CD49d, CD49e, CD6liCD63 on CD34- cells atday 4 of cell culture. a and e




















































































































FLl-H\CD4SE F!TC-> IFLI-H\CD49E FITC_}
8fl% Log ! 80% Log
1 t 1
FLI-H\CD61 F|TC-> FLI-H\CD61 FITC->
FIG. 3.3.12. Contoru plots showing the effects of fibronectin on
co-expression of CD4 9 dl CD 63, CD49 e I CD63 and CD6 I /CD63




























































FIG. 3.3.13. Effects of fibronectin on co-expression of CD4gd/CDlsl,
CD49elCDl5l and CD61/CD15I on CD34* and CD34* cells at day
4 andday 8 of culture. Results are shown as the meanlSD (n:4).
*p:0.043 significantly higher than the liquid culture.
**p:0.039 significantly higher than liquid culture.
of the cultures, the percentage of CD49d/CD151 and CD49elCD15l was not different at
day 4.
At day 8 on CD34* cells, the presence of fibronectin resulted in a slightþ increased co-
expression of cD4gd/cDl5l (Tgo/otl' vs 55Yot4.3) as compared with liquid culture. The
co-expression of CD49e/CDlsl (27%xl2 vs 10%11.6) on CD34+ cells was increased
significantly in the presence of fibronectin ((IF0.02) as shown in Fig- 3-3.13- The co-
expression of CD6l/CDl5l \ilas no different in both cultr¡res at this time point.
When compared day 4 and day 8, CD34* cells were cultured with fibronectiq it was noted
that co-expression of CD49d/CD15l, CD49elCDl5l was not significantþ different
between the two time points. However, co-expression of CD6l/CDl5l was significantly
decreased (38%+10 vs 9.0o/oÐ,.1) as compared wittì day 4 of culture.
For fi¡rther compare of day 4 and day 8 liquid cultures on CD34*cells, it was found that co-
expression of CD49d/CD15l on CD34* not significantly changed. However,
CD49e/CDt5t (g%L2.1 vs 25o/o!7.8) and CD61/CD151 (9%x2.1 vs 23Yo+5.3) co-
expression were significantly decreased at day 8 compared to day 4.
CD34- cell co-expression of CD4gdlcDlsl, CD49e/CDl5l and CD6l/CDl5l also were
investigate d at 4 and 8 days of culture. At day 4, in both cultures, the percentage of co-
expression was not different n CD49í/CD I 5 l, CD49el CDI 5 I and CD6 I /CD I 5 l.
At day 8, There was a similar of co-expression in bottr cultures. When compared day 4 and
day g culhue in presence of fibronectin on CD34- cells, the results shown that co-
expression of CD491/CD151 was increased at day 8 as compared with day 4. However, co-
expression of cD4ge/cDl5l andcD6llcDl5l were decreased at day 8 as compared v'ritlt
day 4.
By contrast, when day 4 and 8 liquid cultures of CD34- cells were compared, no difference
was obtained between co-expression of CD49d/CD15l at these two times. However, in
comparing to day 4, co-expression of CD49elCD15l and CD61/CD151 were reduced by
day 8.
These results indicate that the effect of fibronectin on co-expression of CD6l/CDl51 on
CD34* cells was mainly evident at day 4. However, the effect of co-expression on
CD49d/CDl51 and CD49e/CDl5l was atalater stage'
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3.3.8 DETECTION OF INTEGRIN TETRASPAN CO-
EXPRESSION ON CD34+ CI'LLS BY
IMMT]NOPRECIPITATION
Immunoprecipitation was used to assess physical co-location of integrins and tetraspans in
cultr¡red CD34* cells. CD34* cells were cultured in liquid or with fibronectin in medium
containing the standard cytokines for 4 days. The cells were then collected and
immunoprecipiøtion procedures performed. The tetraspan antibodies were used as the
primary immunoprecipitating antibody. The integrin antibodies were used to identiff the
whether the respective integrin co-precipitaæd with the tetraspan. The results of
immunoprecipitation of integrin cD49d and cD49e proteins with cD63 and cDl5l
proteins a¡e shown in Fie.3.3.14. Two bands were evident from the CD49d/CD63
immunoprecipitate derived from cells of both liquid and fibronectin cultr¡re Fig 3.3.144'
lane 1 and 4: MW bands of 57kDa and 28lDa. The second band of 28kDa" however' was
more easily identified from cells gfown in liquid culttlre.
CD49elCD63 immunoprecipitate Fig.3.3.14 a. lane 2 and lane 5 was identified as a MW
band of 44trÐu CD6l (Pg) also immonoprecipitated ì¡rith CD63 Fie 3.3.14 a- lane 3 and
lane 6 with two MW bands,S7k'Daand 28kDa'
CD49d/CDl5l immwroprecipitate had a similar MW band of 57kDa to CD49í/CD63
(Fie.3.3.14 b lane 1 and lane 4. Similarly, the CD49e/CD15l immwroprecipitate has a MW
band of 4ily,Dasimila¡ to that of CD49elCD63 immunoprecipitate (Eig3.¡.t+ l,lane 2 and
lane 5. The CD61 lcDlsl immunoprecipitate had rwo MW bands of 57kDa and 28kDa
similar to that of CD61/CD63 immunoprecipitate Fig.3.3.14 b, lane 3 and lane 6. However,
in this study, precipitation of integrins/CDl5l molecules in the rage 110-l50kDa (Fitter et
at., lggg) was not detected by immunoprecipitation from anti-cDl5l. Furthermore, the
large of MW band (110-l50kDa) precipitation of integrins/CD63 from anti-CD63
immunoprecipiøtion was not detected either. The failure to detect the large molecule could
be the experiment containing SVo of 2-metcaptoethenal in the loading buffer to run
SDS/pAGE. The data suggest that tetraspans CD63 and CDl5l physically co-locate with














49d 49e 6l 49d 49e 6l
FIG. 3.3.14 Immunoprecipitation of integrins associated with
tetraspans. Western blots of SDS-PAGE a¡e showing immuno-
precipitation of integrins CD49d and CD49d and CD61 with
tetraspans CD63 and CDl5l from liquid and fibronectin cell
cultures. The method of western blots and immunopre-cipitation










3.4THE EFFECT OF INTEGRIN AND TETRASPAN
ANTIBODIES ON MK PROGENITOR CELLS IN
STROMAL CELL CUTURE
INTRODUCTION
Bone m.oow stomal cells are known to provide essential environmental factors invivo for
the grorvth of haemopoietic cells. These factors include extracellular matix @CM) like
fibronectin, and haemopoietic growth factors. An in vitro CD34* cell microenvironment
was developed using a mouse stomal cell line which provided direct cell-to-cell and/or
cell-ECM contact in the presence of standard cytokines and MGDF. CD34+ ceils were co-
cultured on confluent stromal cells to evaluate the ability of stromal cell to support CD34+
cells growth invitro.
In order to examine the role of integrins and tetraspan in the g¡owttr of MK progenitor cells,
CD34* cells were cultured in the presence and absence of the blocking antibodies anti-
CD49d, anti-CD49e and anti-CDlsl. Non-blocked and blocked cells were further co-
cultured with stromal cells to examine the effect of blocking and sfomal cells on cell
proliferation and differentiation. GFU-MK assay and expression of adhesion and ætaspan
molecules were used to assess the role of integrins and tetraspan in stromal dependent
megakaryocytopoiesis.
g.4.I EFFECT OF STROMAL CELL CT]LTTIRE ON
THE PROPORTION OF CD34* CELLS
CD34+ cells were co-cultured with stromal cells or in shomal free culture over 8 days'
There were a significant increase in percentage of CD34+ cells in the presence of stromal
cells (p:0.009) compared to stromal free culture,24.5%o +3.3 vs 5.7o/o !2.8 (mean +sD,
n:3) Fig. 3.4.1. These data confirmed that stromal cells have an interactive role in and/or
















FIG. 3.4.1. The effect of süomal cells on CD34 cell proliferation.
The CD34* cells were cultured in stromal free or stromal cell
culture for 8 days. CD34*cells were analysed by flow cytometry.
CD34* cell numbers were significantly higher in süomal cell


















9.4.2 EFFECTS OF INTEGRIN AND TETRASPAI\
BLOCKING ON TOTAL CELL COT]NT
In order to examine the role of integrin and tetaspan on CD34+ cell proliferation and
differentiation to MK progenitors, the effect of blocking antibodies to these molecules was
investigated. CD34+ cells were incubated with monoclonal antibodies against CD49d'
cD4ge and cD151 for 30min at 40c. These cells were further cultured with confluent
stromal cells for 4 and 8 daYs.
The results are shown in Fig 3.4.2. A totat of 2xl0a non-blocked cell increased26.5 !4.3-
fold (mean +SD, n:3) by day 4, and 58+7-2-fold (mean +SD, n:3) by day 8'
Effect of anti-CD49d on CD34+ cell count. With blocking of CDtgd cell count increased
10.5+3.6-fold (mean +SD, n:3) by day 4, with declining to 8.5 14.4-fold increase (mean
+SD, n:3) by day 8. In the presence of CD49d blocked with antibody, cell proliferation
was significantly inhibited at both day 4 (IF0.04) and day I (IF0.0021).
Effect of anti-CD49e on CD34* cell count. Similar results were seen with blocking
CD49e function. On day 4, there wasi an 8.5+1.2-fold (mean +SD, n:3) increase and by day
g a 9.5t2.2-fold (mean +SD, n:3) increase. The inhibition of cell proliferation was
significant atday 4 (p{.04) and also atday S (IF0'021)'
Effect of anti-CDlsl on CD34* cell count. On day 4, there was a 9.2+ O.9'fold (mean
tSD, n:3) increase in CD34+ cell corxrt and by day 8, a 10.3t3.7 fold (mean +SD, n:3)
increase compared with day 0. The inhibition of cell proliferation was significant (p:0.04)
at day 4 and (p:0.021) at day 8. Thus, these results suggest that integrins, CD49d, CD49e
and tetraspan CD151 are required by CD34*cells for proliferation.
3.4.3 TIIE EFF'ECT OF INTERGRIN AI\D TETRASPAI\
BLOCKING ON PROPORTION OF CD34* CELLS
Fie. 3.4.3 is a representative contour plot showing the percentage of CD34* at day 8 in
stromal cell cultures containin g CD34+ cells inhibited by the respective antibody to CD49d,
CD¡geand CDl51. The percentage of CD 34*cells was24.5Vo+7.2inthe control (non-



















FlG.3.4.2.Effect of anti-CD4gd,CD4ge and anti-CD15l ontotal cell count. CD34* cells
were blocked by anti-CD49d, CD49e and CDl5l for 30 min at 40C, then co-cultured with
stromal cells for 4 and 8 days. In this experiment non-blocked CD34* cells were used as
control. The results are presented as meantSD (n:4).
p:0.04 three of different anti-blocking cell count were significantly low than non-blocked
cells at day 4.
p:0.021 three of different anti-blocking cell count were significantly low than non-













































Ç 50% Log 50% Log
I I 0 t 0 0
SSC-H\SSC-Height-> SSC-H\SSC-Height->
50% Log 50% Log
0 1
SSC-H\SSC-Height-> SSC-H\SSG-Height->
FIG.3.4.3. Representative effects of blocking antibody on the
percentage of CD34* cells at day 8. Results a¡e shown in the contour
plots. A:non-blocked cells (30.6%), B:anti-CD49d blocking (41.5%),
C:anti-CD49e blocking (44.3%), D:anti-CDl5l blocking (61.9%).












containing the inhibiting antibodies. In the previous sectior¡ the data showed an inhibition
of proliferation of CD34* cells by the inhibiting antibodies. The data from both sections
taken together suggest that blocking of integrin/tetraspan function results in inhibition of
cell proliferation and maturation and that inhibition of tetaspan has a greater effect on
maturation,
3.4.4 EFFECT OF INTEGRIN AI\ID TETRASPAI\ BLOCKING ON
MK PROGEIUTOR DEVELOPMENT AS ASSESSED BY
EXPRESSION OF MK MARKERS (CD61' CD42b) AI\D ON
EXPRESSION OF TETRASPAI\ CD151
To clarif the important roles of CD4gd, CD49e and CD151 in mediating MK progenitor
cell development, the expression of MK markers CD61 and CD42b were studied following
blocking by anti-49d and anti-49e antibodies. Expression of CDl5l was also performed at
day 4 and 8.
Anti-CD49d blocking resulted in a significantly reduced CD61 MFI at day 4 (16'5t4.2 vs
30+2.0 mean tSD n:4) þ:0.043), and CD61 remained to reduce NßI (22.6t0.8 vs
2g.6J:0.7) atday 8. Howevet, atday 8 the difference was¡ not significant compared to non-
blocking cells respectively Fig 3.4.4 (.a). No signifrcant difference for CD42b MFI was
noted at day 4 and 8.Fie 3.4.4(b). Anti-CD49d blocking signifrcantþ reduced CD15l MFI
Q7t\.6vs 48Ð,.7,meantsD n:4) þ:0.043) at day 4. However, by day 8 cD151 MFI has
recovered Fie 3.4.4(c).
similarly, cD61 MFI was reduced at day 4 by blocking cD49e (21t7 -2 vs 30L2.2
mean+SD n=4), CD6l MFI remained reduced at day 8. The MFI of CD42b and CDl5l
was not altered by blocking CD49e over 8 days of culture Fie.3.4.5. The reduction of
cD61 MFI by blocking cD4gd and cD49e was greater than cD42b. However, the effect
of blocking CD4gdon CD151 was seen early at day 4. Integrin CD49d but not CD49e
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FIG. 3.4.4 Effect of CD49d blocking on expression of MK markers.
Histograms MFI of CD6l, CD42b and CDl5l expression with or without
blocking.






































FIG. 3.4.5. Effect of CD49e blocking on expression of MK
markers. Histograms showed the MFI of CD61, CD42b arrd
CDl5l expression with or without blocking. There was no
significant difference in MK marker expression following
blocking.
3.4 5 EFFECTS OF INTEGRIN AI\D TETRASPAI\
BLOCKING ON CFTI-MK F'ORMATION
The influences of anti-CD49d, CD49e, and CD151 blocking on MK progenitor cell
proliferation and differentiation were evaluated by using the CFU-MK assay. The CD34+
cells were incubated for 30 min with or without anti-CD49d, anti-CD49e and anti-CDl5l
and were then co-cultured with stromal cells. After 4 days, cells were collected and
subcultured in semi-solid agar for a flirther 14 days, when the CFU-MK colonies were
identified and cowrted.
The contol cultu¡es (no blocking of CD34* celts) showed significantþ higher CFU-MK
colonies than any of the blocked cultures Fig.3.4.6 (pF0.029). Based on CFU-MK assay'
integrins CD49d, CD49e and the associated tetraspan CDl5l play an important role in MK
progenitor cell proliferation and differentiation-
3.4.6 MORPHOLOGY AND DEYELOPMENT OF MK COLONIES
WITH INTEGRIN AI\D TETRASPAI\ BLOCKING
CFU-MK progenitor cells were detected by their capability to fonn MK colonies in semi-
solid culture. CD34* cells, unblocked or blocked by anti-CD49d, anti-CD49e and anti-
CDl5l were co-cultured on stromal cells and at days 4 and day 8 subcultured to semi-solid
agar culture for a further 12 days. The frequency of MK was identified by APAAP staining'
the colonies labelled with the anti-GPtrbllla and anti-GPIIIa monoclonal antibodies. The
distribution of MK colonies is shown inF\g3.4.7. In cells derived from 4 days of culture,
the anti-CD 49d, anÍi-CD49e and anti-CDl5l blocked CD34* cells showed significantly
reduced numbers of MK colonies Fig 3.4.7 A. B. C, compared with the CD34* control:
from 20-50 vs 50-100 at day L2 of colony growth Fig 3.4.7 D. Subculturing from day 8
cultures, the MK colony generation was similar to that from day 4 cultues, with the control
cells showing significantþ higher colony number (Fie 3.4.7 fÐ- than the anti-CD49d,
CD4geand CDl5l blocked cetls Fie. 3.4.7 E. F. G. MK-colony formation from CD34+



























Control Anti4D49d Anti4D49e Anti4D151
FIG.3.4.6. Effect of anti-CD49d, anti-CD49e and anti-CDl5l blocking on MK
commitment lineage. CD34+ ceils were blocked by anti-CD49d, arfü-CD49e and anti-
CD151 for 30 min at 40C, then co-cultured on stromal cells for 4 days. 1x103 cells were
subcultured in semi-solid agar for frrther 12 days to identify CFU-MK. The results
shown as the meantSD (n:4).





























































































FIG. 3.4.7 Microphotographs of CFU-N{K. CD34* cells were blocked by anti-CD49d, anti-
CD49e and anti-CDlsl for 30 min at 40C, and co-cultrued in stromal cells in 4, 8 days. The
cells were collected and culflred for further 14 days in semi-solid agar culture with standard
cytokines and MGDF. The experiment was added control as well. The CFU-MK colonies
were photographed after APAAP staining. Anti-CD49d blocking (A), anti-CD49e blocking
(B), anti-CDlsl blocking (C), and Control (D), at day 4 in the stroma cells. Original
magnification x 250.
Anti-CD49d (E), anti-CD49e (F), anti-CDl5l (G), and control (H), at day 8 in the stromal cell




Normal haemopoiesis is regulated by a complex set of factors of the haemopoietic
microenvironment. These factors consist of haemopoietic growth factors, ECM molecules
and stromal cells each interacting with haemopoietic stem cells to direct the coordinate
regulation of blood cell development. The role of interaction of ECM and BM stromal cells
in the differentiation of erythroid and myelomonocytic cells has been reported (tMilliams et
al, l99l; Yanai et al,1994), but there is a dearth of study in regard to megakaryopoiesis. In
this study, using CB blood as a source of CD34* stem cells the role of BM
microenvironment on MK differentiation and proliferation was studied in vitro-
Understanding the mechanisms of regulation of MK progenitor diffetentiation may help in
the development of optimal in vitro cultr¡¡e conditions for the expansion of MK progenitors
for transplantation theraPY.
Several studies have shown that ECM proteins are important in regulating haempoiesis
(Simmons et aL, 1994, Dexter et al, 1997; Yoder and Williams, 1995; Verfaille et aI, 1994).
The integrin superfamily molecules which are receptors for ECM are expressed on HSC
and on süomal cells (Simmons et al, 1994;. Verfaille et al, 1994). fr" pt integrins may
play arole in regulating haemopoiesis (Miyake et,l99!; Williams et al, l99l; Yanai et al,
1996; Rosemblatt et al, 1991). The integrins CD49d and CD49e, both of which are
fibronectin receptors, are believed to be important mediators of direct interaction of
haemopoietic progenitors and ECM (Miyake et,l99l; Williams et al, 1991; Yanai et al,
1996; Kerst et a!, 1993; Teixido et aI, 1992). The study has confirmed that CD49d was
highly expressed on fresh CD34* cells but CD49e was weakly expressed. There are
literature evidence that CD49d and CD49e associate with the tetraspan family which may
have a role in the modulation of integrin function possibly involved in transmembrane
signalling (paul, M. et al lggT). Expression of a panel of tetraspan molecules on CD34+
cellswere examined: CD9, CD53, CD63 and CDl51. In this study, CD63 and CDl5l were
chosen for further study because the expression of CD63 was higher (21.1% 11.2) than the
other tetraspnrìs on CD34+ ce[s and in culture with cytokines its expression increased
further. Although fresh CD34* cells expressed low level of CDl5l (6.5% +1.4), however,
CDl5l is expressed on megakaryocytes and platelet (Fitter et a1.,1999). Also CDl51 was
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found on haematopoietic cell lines, M07e, HEL and K562 @itter et al., 1999). CD9 and
CD53 were expressed at level lower than CD63 and CDl5l on CD34* cells at day 0 and
their expression did not increase with culture and were, therefore, excluded from fi¡rther
study.
A serum-free cultr¡re medium was used to study the role of ECM in regulating MK
progenitor cells development. The base medium contained IJ.i-3,IL-6 and SCF which were
found to maintain well CD34* in culture. The addition of MGDF in combination with IL-3,
IL-6 and SCF was a potent stimulator of MK progenitor cells differentiation. MK
progenitors differentiation was monitored using the CFUMK colony assay and by flow
cyûomeûy for expression of CD61 and CD4la" the MK lineage markers. 39o/o of CD34*
cells expressed CD61 at day 0. However, with in vitro culture, both in the presence and
absence of MGDF, expression of CD61 on CD34+ cetls had fallen to <l0Yo, by day 4.
However, expression of CD61 was slightþ higher in the Presence of MGDF. CD34+ cells
expression of CD61 recovered significantþ in the presence of MGDF by day 8. On the
other hand, the expression of CD61, which was just above lOYo onCD34- cells at initiation
of cultwe, increased to above 20%by day 8. Thiagarajan and co-workers (1985) reported
that CD6l was detected on endothelial cells, monocytes and fibroblasts. It appears that
CD6l though an early MK lineage ma¡ker is not a specific marker for the megakaryoc¡ic
lineage. Although cord blood contains MK progenitors, the initial expression of CD61 on
CD34* cells probably does not reflect MK differentiation entirely. In this study, CD41
expression was not examined. In later studies involving fibronectin or stromal cells, the
late increased in CD6l expression was associated with increased CD4l expression. Hence,
the subsequent rise in CD61 in both CD34* and CD34- cells most likely reflected
maturation of MK progenitors.
This study confirmed that MGDF is an important physiological regulator of
megakaryopoiesis. MGDF, as a single growth factor, can stimulate growth of CFU-MK
colonies from CB. However, MGDF with either IL3 or IL6 alone respectively in culture
was found to produce less CFUMK colonies than MGDF alone. This agrees with the
finding of Nichol et al (1995) that IL-3 and IL-6 may be inhibitory of MGDF-induced MK
colony formation in vitro. The cytokine combination of SCF, IL3 and IL6 supported MK
progenitors development. Addition of MGDF with these cytokines increased MK
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progenitor differentiation but did not alter CD34* cell proliferation. This increase of MK
progenitors was confirmed by the CFUMK assay (Fig3'1'3)'
Several studies have indicated that p1-integrins play a role in erythropoiesis and
myelomonocytic differentiation. This study provides information regarding the role of
these integrins and ECM in megakaryopoiesis. MGDF altered the expression of CD49d
and CD49e suggesting that these p1-integrins may play a role in megakaryopoiesis. MGDF
initially decreased the high expression of CD49d on CD34* cells but its expression
increased to moderate level by day 8. In contrast, MGDF increased the expression of
CD49e on CD34* cells over the 8 day culture. Cui et al (1997) demonstrated that MGDF
increased the adhesion of the lvfk leukaemic cell line MoTe to fibronectin as well as
vascular cell adhesion molecule-l through activation of CD49d and CM9e. The
observation in this study that both CD63 and CDl5l coexpression with CD49d was
increased by MGDF is consistent with the activation of CD49d. MGDF has little effect on
the co-expression of CD63 and CDl5l \¡rith CD49e indicating that it did not activate
CD49e.
The effect of fibronectin was used a model for the effect of ECM on MK differentiation.
Fibronectin had no effect on total cell number but did increased the number of CD34+ cells
over culture indicating that fibronectin preserved CD34* cells during culture. Fibronectin
increased the differentiation of MK progenitors as evident by the increased expression of
CD61 and CD4la on CD34* cells and CD34'cells. This was confirmed by the CFU--MK
assay. Fibronectin upregulated the expression of CD49d and CD49e on both CD34* and
CD34' cells. Thus, these data suggest that ECM eg fibronectin augmented the
differentiation to MK precursors of CD34+ cells through its adhesive interaction with
CD34* cells. Finally, that fibronectin regulates MK differentiation through interaction with
p1-integrins is strengthened by its upregulation of the expression of both CD49d and CD49e
with ttre associated tetaspans cD63 and CD151, on cD34+ and CD34- cells' That
tetraspans CD63 and CDl5l are most likely the signal transducers of CD49d and CD49e is
confirmed by the following observations : i) their co-expression with CD49d and CD49e, ii)
the upregulation of the coexpressions by fibronectin and iii) their physical association with
CD49d and CD49e as indicated by their co-precipitation. This study is the fust report
describing the presence of integrin/tetraspan complexes on cD34 cells and their
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upregulation by fibronectin. Fibronectin increased MK diflerentiation is most likely
through a Þ r-integrin-ligand interaction.
A mouse bone manow stromal cell line, MS-5, was used to mimic a HSC
microenvironment to study MK-progenitor differentiation in vitro and the role of p1-
integrins in this differentiation. MS-5 stromal cells increased total and CD34+ cell counts
confirming their supportive role for haemopoiesis. The role of integrins CD49d, CD49e,
and the associated tetaspan CDl5l in MK diflerentiation was studied in this stromal cell
microenvironment. Anti-CD49d, anti-CD49e and antfCDl5l significantþ inhibited CD34*
cells proliferation. Thus, interaction with CD49d, CD49e and CDl5l potentially regulates
CD34* cells proliferation. Blocking of the p1-integrin CD49d affected expression of MK
lineage markers CD6l and tetraspan CDl5l but not CD49e. However, anti-CD49d, anti-
CD49e and anti-CD15l inhibited stromal cells induced MK-progenitor differentiation as
monitored by CFU-MK assay. The results indicate that adhesive interaction of CD34+ cells
with sfomal microenvironment most likely fibronectin is an important mechanism for
megakaryopoiesis. CDl5l was first identified as a novel hr¡man platelet surface
gþoprotein" and has co-localisation with Þr-integrins (Sincock et aI, 1997; Fitter et al,
1999). It has a role in platelet aggregation (Roberts et al, 1995). This study provides the
first evidence that the tetaspan CDl5l is a signal transducer for the p1-integrins in the
induction of megakaryopoiesis. CD6l is also important in platelet aggregation through
binding of fibrinogen. An agonist antibody to CDl5l induced platelet aggregation
indicating that it is the likely signal tansducer for CD61 following its interaction with
fibrinogen. This study showed that CDl5l is already associated vrith CD61 (Gpma) at the
progenitor level. However, the role of CD6l in megakaryopoiesis was not studied, but as
MGDF did upregulate the co-expression of CD15l and CD6l early, future study should




Abboud" M., XrL F., LaVia M, et al. (1992). Study of early haematopoietic precwsors in
human cord blood- Exp Hematol.20' 1043.
Alberico, T.A., Ihle, J.N., Liang, C.M., et al. (19S7). Stromal growth factor production in
irr¿diated lectin exposed long-tenn mr¡rine BM culture. Blood 69,1120'
Andrews, F.G., Singer, J.W., Eernstein, I.D. (1989). Precursors of colony-forming cells in
humans can be distinguished from colony-forming cells by expression of the CD33 and CD
34 antigens and lighter properties- J Exp Med. 169' 1721.
Aïai, K., Iæe, F., Miyajima 4., et al. (1990). Cytokines: coordinators of immune and
inflammatory responses. Annu Rev Biochem- 59,783.
Avralram, H. (1993). Regulation of megakaryocytopoiesis. Stem Cells 11,499'
Ayala I. A., Tomer,4., Kellar, K.L.(1996). Flow cytometic analysis of megakaryocyte-
associated antigen on CD34 cells and their progeny in liquid culture. Stem Cells 14:320.
Bartha" K., Brisson, C., Archipoff, G., et al. (1993). Thrombin regulates tissue factor and
thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by
distinct mechanisms. J Biol Chem.268,421.
Bartley, T.D., Bogenberger, J., Hunt, P., et aL. (1994). Identification and cloning of a
megakaryocyte growth and development factor that is a tigand for the cytokine receptor
l'frpl. Cell77,lllT .
Berditchevski, F., Bazzoni, G., Hemler, M.E. (1995). Characterisation of novel complexes
on the cell sr¡rface between integrins and proteins with 4 transmembrane domains (TM4
protein). Mol Biol Cell7,I93.
Briddell, H., Vannier, E., Cowloy, S., et al. (1992). Effect of the stem cell factor, c-kit
ligand, on human megakaryocytic cells. Blood79,365'
Bruno, E., Briddell, R., Hoffinan R. (19S8). Eflect of recombinant and purified growth
factors on human megakaryocyte colony fonnation. Exp Hematol. 16,371'
Bruno, E., Hoffinan, R. (1989). Effect of interleukin-í on in vitro megak'aryocytopoiesis:
Its interaction with other cytokines- Exp Hematol. 17, 1038'
Burridge, K., Fath, K., Kelly, T., et al. (198S). Focal adhesions: transmembrane junctions
between the extracellular matrix and the cytoskeleton. Annu Rev Cell BioL 4' 487 -
68
Caracciolo, D., Shirsat, N., 
'Wong, G.G. (1987). Recombinant human macrophage colony-
stimulating factor (M-CSF) requires subliminal concentations of granulocyte/macrophage
(GM)-CSÈ for optimal stimulation of human macrophage colony formation in vitro- J Exp
Med. 166,1851.
Chabannon, C., Torok-Storb, B. (1992). Stem cell-stromal cell interaction. Exp Hematol.
r77,123.
Corash, L., Levin, J., Moþ Y., et at. (19S9). Measurement of megakaryocyte frequency and
ploidy distribution in unfractionaed muine bone ma¡row. Exp Hematol. 17,278.
Coulombel, L., Eaves, C.J., Eaves, AC., et al. (1933). Enrymatic treatnent of long-term
human marrow cultures reveals the preferential location of primitive hemopoietic
progenitors in the adherent latet Blood 62,291.
coulombel, L., vuillet, M.H., L,eroy, c. (lgss). Lineage and stage-specific adhesion of
human haematopoietic progenitor cells to ECM from bone marrow fibroblast. Blood 71,
329.
Cui, L., Rarnsfiell, V., Borge, O.J., et aJ,. (L997). Thrombopoietin promotes adhesion of
primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-l. J
Immunol. 159,1961.
Civin, C.I., Strauss, L.C., Brovall, C., et al. (1984). Antigenic analysis of haematopoiesis.
n. A haematopoietic progenitor cell sr¡rface antigen defined by a monoclonal antibody
raised against KG-la celIs. J Immunol. 133,157.
Civin, C.I., Banuerigo, M.L., Strauss, L.C. (1987). Antigenic analysis of haematopoiesis.
VI. Fíow c¡ometric characterisation of My-10 positive progenitor cells in normal human
bone ma¡row. Exp Hematol.15, 10.
De Bruyn, C., Delforge, A. (1995). Comparison of the coexpression of CD38, CD33, and
HfA-On antigens on CO3+*purified cells from human cord blood and bone matrow. Stem
Cells 13,281
De Sauvage, F.J., Hass, P.8., Spencer, s.D., et 41. (1994). Stimulation of
megakaryocytopoiesis and thrombopoiesis by the c-Mpt ligand. Nature 369'533-
Demetri, D.D., Bukowski, R.M, Samuels, B., et al. (1993). Stimulation of thrombopoiesis
by recombinant human interleukin 6 (IL-6) pre and post chemotherapy in previously
untreated safcoma patients with normal haematopoiesis. B/ood 82 (suppl)'367a'
Dexter, T.M., Lajtha" L.G. (1974). Proliferation of haemopoietic stem cells invitro. Brit J
Haematol.28,525.
69
Dexter, T.M., Allen, T.D., Lajth4 L.G. (1977). Conditions controlling the proliferation of
haematopoietic stem cells iz vitro. J Cell Physiol.9l' 335'
Dexter, T.M. (1979). Cell interactions in vitro. clin Haematol. 8,453.
Dexter, TM. (1982). Stromal cell associated haemopoiesis. J Cell Physiol' 1,87 -
Donshkind, K. (1990). Regulation of hemopoiesis by bone m¿urow cells and their products.
Annu Rev Immunol. 8, 11 1.
Dreger, P., Marquardt, P., Haferlach, T.J., et al. (1993). Effective mobilisation of
p"ti[né*f 6too¿ irogenitor cells with "Dexa-BEAM" a¡rd G-CSF: Timing of hawesting
andìomposition of the leukapheresis product. Brit J Cancer 68,950.
Edelmaq G.M. (lgs5). cell adhesion and the molecular processes of morphogenesis. Annu
Rev Biochem. 54,135.
Edelman, G.M., Crossin, K. L. (1991). Cell adhesion molecrls5¡ imFlications for a
molecula¡ histology. Annu Rev Biochem- 60,155.
Emonard, H., Calle, A., Grimaud, J.4., et al. (1990). Type IV and interstitial collagenol¡ic
activities in normal and malignant trophoblast cells are specifically regulated by the
extracellula¡ matrix. Invasion Metast. 10, 170.
Faull, R.J., Kovach, N.L., Harlar¡ J.M., et al. (1994). Stimulation of integrin-mediated
adhesion of T tymphocytes and monocytes: Two mechanisms with divergent biological
consequences. J Exp Med. 179,1307.
Fitter, S., Tetaz T.J, Berndt M.C. (1995). Molecular cloning of oDNA encoding a novel
platelet-endothelial cell tetraspan antigen, PETA-3. Blood 86, I348.
Fitter, S., Sincock, P.M., Jolliffe, C.N., et al. (1999). Transmembrane 4 superfarnily protein
CDl5l (pETA-3) associates dú pt and ollbp3 integrins in haemopoietic cell lines and
modulates cell-cell adhesion. J Biochem. 338, 61.
Frennetteo P. (1996). Molecular medicine. New Engl J Med.334,1528.
Gewirtz, A.M. (1990). Use of in situ hybridisation to study human megakaryocyte gene
expression. Pro Clin Biol Res.356, 105-
Gewirtz, A.M. (1995). Megakaryocytopoiesis: The st¿te of the art. Thromb Haemost 74,
204.
Ginsberg, M.H., Loftus, J.C., Plow, E.F. (19S8). Cytoadhesions, integrins and platelets'
Thromb Haemost.59, 1.
70
Glancotti, F.G., Comoglio, P.M. (19S9). Fibronectin plasma membrane interaction in the
adhesion of haematopoietic cells. J Cell Biol. 103,429.
Golde, D.W. (1935). Hematopoiesis' In Gewirtz, 4.M., Hoffinan, R'
Magalraryocytopoíesis (l't). page, 8 l.
Goodman, J.W. (1960). Bone m¿uïow cell separation studies. Expl Cell.Res. 21, 88.
Gordon, M.Y., Greaves, M.E. (1989). Physiological mechanisms of stem cell regulation in
BMT and haemopoiesis. Bone Marrow Transplantation 4,335.
Gordon, M.Y., Clarke, D,, Atkinson, J., et al. (1990). Hemopoietic progenitor cell binding
to the stromal microenvironment in vitro. Exp Hematol. L8,837.
Gospodarowicz, D., Ill, C. (1930). Exracellular matrix and control of proliferation of
vascular endothelial celLs. J Clin Invest.65, 1351.
Gualtieri, R.J., Shadduck, R.F., Baker, D.G., et al. (1984) Hematopoietic regulatory factors
produced in long-term bone ma¡row cultr¡¡es and effect of in vitro irrradiation. Blood 64'
516.
Guan, J.L., Hynes. R.O. (1990). Lymphoid cells recognize arLalternative spliced segment of
frbronectin via the intergrin receptor a+þr Cell60, 53.
Gumey, 4.L., Carvef-Moore, K., de Sauvage, F.J., et al. (1994). Thrombocytopenia in c-
mpl-deficient mice. Science 265, 1445.
Hanspal, M. (1997). Importance of cell-cell interactions in regulation of erythropoiesis'
Curr Opin Hematol. 4, 142.
Harker, L.A. (1968). Megakaryocyte quantitatíon. J clin Invest. 47,452.
Hay, E.D. (1991). Cell biology of extracellular matrix.(2"d),Pã8e,113. Plenum press, New
York and London.
Hemler, M.E., Huang, C., Takada" Y., et at. (1987). Characterisation of the cell surface
heterodimer vLA-4 and related peptides. J Biol. chem. 262,11478.
Hemler, M.E. (1990). VLA proteins in the integrin farnily: structures, functions and their
role on leukocytes. Annu Rev Immunol.8,365.
Hoffrnan, R., Yang, H.H., Bruno, E., et al. (1985). Purification and partial characterisation
of a megakaryocyte colony stimulating factor from human plasma. J Clin Invest. 75,ll74'
Hogg, N. (1989). The leukocyte integrins. Immunol Today l0' 1l l '
7l
Horie, K., Miyazaki, H., Hagiwar4 T., et aI. (1997). Action of thrombopoietin at the
megakaryocyte progenitor level is critical for the subsequent proplatelet production. Exp
Hematol.25,169.
Hynes, R.O. (1992). Integfins: versatility, modulation and signalling in cell adhesion. Cel/
69,LL.
Ishbashi, T., Kimura, H., Shikama Y., et al. (1990). Effect of recombinant granulocyte-
macrophage colony stimulating factor on murine thrombocyþoiesis in vitro altd in vivo.
Blood75,1433.
Itoh, K., Tezuka, H., Sakod4 H., et at. (1989). Reproducible establishment of hemopoietic
supportive stromal cell lines from murine bone ma¡row. fup Hematol' L7,145'
Kaushansþ, K. (1995). Thrombopoietin: The primary regulator of platelet production.
Blood86,4l9.
Kerst, J.M., Sanders, I.C.M., Slaper-Corterbrch, M.C., et al. (1993). ø+Þr and ospr il9
differentially expressed during myelopoiesis and mediate the adherence of human CD34+
cells to fibronectin in an activation-dependent way. Blood8l,344-
Klein, G. (1995). The extracellular matrix of the hematopoietic microenvironment-
Experientia 51,914.
Kleinman, H.K., McGarvey, M.L., Stal, V.L., et al. (1937). Basement membrane
complexes with biological activity. Biochem- 25,312'
KovactU N.L., Lin, N., Yednoclq T., et al. (1995). Stem cell factor modulates avidity of
cr¿Þr and asÞr integrins expressed on hematopoietic cell lines. Blood 85, 159.
Krause, D.S., Fackler, M.J., Civin, C.I., et 41. (1996). CD34: Structure, biology, and
clinicat utility. Blood 87,1.
Laure, C., Isabell e, A. (1997\. Expression and function of integrins on hematopoietic
progenitor cells. Acta Haematol. 97, 13 -
LeraI,H., Lissitzþ, J., Singer, J., et al. (1993). Role of stromal cells and macrophages in
fibronectin biosynthesis anã matix assembly in human long-term marro\¡/ cultures- Blood
92,1480.
Levesque, J.P., Leavesley, D.I., Niutta" S., et al. (1995). Cytokines increase human
hemopoietic cell adhesivlness by activation of very late antigen (VLA)-a and VLA-5
integrins. J Exp Med. L81,1805.
Lichbnan, M.A. (1981). The ultastructure of the hematopoietic environment of the
manow: a review. ExP Hematol. 9, 391.
72
Lichünaru M.A. (19g4). The relationship of stromal cells to hematopoietic cells in marow.
Kroc Found Ser- 18, 3.
Liesveld, J.L., Abboud, c.N., Duerst, R.E., et al. (1989). Cha¡acterisation of human
marrow stromal cells: role in progenitor cell binding and granulopoiesis. Blood73,1794.
Liesveld, J.L., Matti,8. 4., Harbol,4.W., et al. (1998). Effect of stromal cell coculture on
progenitor cell expansion and myeloid effector function in vitro. J Hematother. 7 ' 127.
Lok, S., Kaushansþ, K., Holly, R.D., et al. (1994). Cloning and expression of murine
thrombopoietin cDÑA and stimulation of platelet production fi¿ vivo. Nature 369,565.
hrg, M.W., Gragowski,L.L.,Heffirer, C.H., et al. (1985). Phorbol diesters stimulate the
deve-lopment of an early m¡rine progenitor cell: The burst forming unit-megakaryocyte
(BFU-MK). J Clin Invest.76,43l.
hrg, M.'W., Wich4 M.S. (1992). Hand book of the hematopoietic microenvironment,
page,26,60. The Johns Hopkins University press, 1'
hrg, M.W. (lgg2). Blood cell cytoadhesion molecules. Erp Hematol. 20,288'
Lotem, J., Shabo, Y., sachs, L. (1989). Regulation of megakaryocyte development by
interleukin 6. Blood 74,1545.
Mazur, E.M., Hoffinan, R., Bruno, E., et 41. (1981). Immunofluorescent identifrcation of
human megakaryocyte colonies using an antiplatelet glycoprotein antiserum. Blood 57 '277 '
Metcalt D. (1993). Hematopoietic regulators: Redundancy or subtlety? Blood82,3515.
Metcalf, D. (1994). Thrombopoietin at last. Nature 369' 519'
Migliaccio, G., Baiocchi, M., Hamel, N., et al. (1996). Circulating progenitor cells in
truman ontogenesis: Response to growth factors and replating potential - J Hematother- 5'
161.
Miltenyi, S., Mäller, W., Weichel, W. (1990). High-gadient magnetic cell separation with
MACS cytomeûry. CYtometrY 11,231.
Miyaka K., Weissman, I. L., Greenberger J.S., et al. (1991)' Evidence for a role of the
intågrin VLA-4 in lympho-hemopoiesis. J Exp Med. 173: 599.
Moore, M. (1975). Embryologic and phylogenetic development of the haemopoietic
system. Adv Biosci. 16, 87 -
73
Mould, A. P., Wheldon" L.4., Komoriyq 4., et al. (1990). Atrrnity chromatographic
isolation of the melanoma adhesion receptor for the mCS region of fibronectin and its
identification as the integrin rl.l4þ1. J Biol Chem' 265,4020'
Nakeff,4., Floeh, D.P. (1976). separation of megakaryocytes from mouse bone marrow by
density gradient centrifugation- Blo od 48, 133'
Nathan, D.G., Oski, F.A. (1937). Hematology of Infancy and childhood, volume 1, (3'5.
W. B. Saunders ComPanY, Page,l28-
Ogawa, M. (1993). Differentiation and proliferation of hematopoitic stem cells. Blood 81,
2844.
Olweus, J., Lund-Johansen, F., Horejsi, V. (1993). CD53, a protein with four membrane-
spanning domains, mediaies signal transduction in human monocytes and B cells' J
Immunol. 151,707.
Pascal, M., Annie, S., Annio, M. (lgg7). Expression and function of receptors for
extracellular matrix molecules in the differentiation of human megakaryocytes in vitro. Brit
J Haem.98, 819.
Patel, V.P., Lodish, H.F. (19S4). Loss of adhesion of murine erythroleukemic cells to
fibronectin ùring eryttroid differentiation. Science 224, 996.
pierschbacher, M.D., Ruoslalrti, E. (1934). The cell attachment activity of fibronectin can
be duplicated by small synthetic fragments of the molecule' Nature 309, 30'
Potts, J., Campbell, I. (1994). Fibronectin structure and assembly. Cun Opin Cell Biol' 6,
648.
Radford, KJ., Thorne, R.F., Hersey, P. (1996). CD63 associates with transmembrane 4
superfamily members, CD9 and CO8t, and with beta I integrins in human melanoma'
Biochem Biopþs Res Commun' 222,13.
Rasko, J.E.J., O'Flaherty, E., Begley, C.G. (lgg7). mpl ligand (MGDF) alone and in
combination with stem tell factor (SCF) promotes proliferation and survival of human
megakaryocyte, erythroid and granulocyte/macrophage progenitors' Stem Cells 15,33'
Roberts, J.J., Rodgers, s.E., Drury, J., et al. (1995). Platelet activation induced by a murine
monoclonal antibody directed against a novel tefa-span antigen. Brit J Haematol.89,853.
Robinson, s.H. Hematopoiesis. (1990). In Stein, J.H., (ed), steins' Intemal Medicine (3'd
ed.). Boston: Little, Brown, Page,8.
Rosales, C., O'Brien, V., Kornberg L. (1995). Signal transduction by cell adhesion
receptors. Biochim Biophys Acta. l3l, 791'
74
Rosemblatt, M., Vuillet-Gaugler, M.H., Leroy, C., et al. (1991)' Coexpression of two
fibronectin receptors, VLA-4 and VLA-5, by immature hr¡man erythroblastic precursor
cells. J Clin Invest. 87,6.
Rubinstein, E., LÆ-Naour, F., Billard, M., et al. (1994). CD9 antigen is an accessory
subunit of the VLA integrin complexes. Eur J Immunol.24,3005.
Ruoslalrti, E., Pierschbacher, M.D. (19S7). New perspectives in cell adhesion: RGD and
integrins. Science 238, 491.
Saeland, s.v., Duvert, C., Caux, D., et al. (1992). Distibution of surface-membrane
molecules on bone marrow and cord blood CD34* hematopoietic cells. Exp Hematol. 20,
24.
Schicþ P.K., Wojenski, C.M., He, J. (1998). Integrins involved in the adhesion of
megakaryocytes to fibronectin and fibrino gen' Blo od 92, 2650'
Schmitz, N., Dreger, P., Suttorp, M., et al. (1995). Primary tansplantation of allogeneic
peripheral blood progenitor cells mobilised by filgrastim (granulocyte colony-stimulating
factor). Blood 85, 1666.
Schwartz, M.A. (1992). Transmembrane signalling by integrins. Trends Cell Biol.2'304.
Seehafer, J.G., Shaw, A.R. (1991). Evidence that the signal initiating memtrane protein
CD9 is associated with small GTP-binding proteins. Biochem Biophys Res Commun. 179,
40r.
Shaw, A.R., Domansk4 4., Gilchrist, 4., et al. (1995). Ectopic expression of human and
feline CD9 in a human B cell line confers pl integrin-dependent motility on fibronectin and
laminin substrates and changed tyrosine phosphorylation. J Biol chem.270,24092.
Siena, S., Bregni, M., Ravagnani, F., et al. (1989). Circulation of CD34* hematopoietic
stem cells in the peripheial blood of high-dose cyclophosphamide-treated patients:
enhancement by intravenous recombinant human granulocyte macrophage colony-
stimulating factor. Blood 7 4, 1905.
Simmons, P.J., Masinovsþ, 8., Longenecker, 8.M., et al. (1992)' Vascular cell adhesion
molecule-l expressed by bone marrow stromal cells mediates the binding of hematopoietic
progenitor celLs. Blood 80, 388.
Sincoch P.M., Mayrhofer, G., Ashman, L.K. (lgg7). Localiz.ation of the transmembrane 4
superfamily (TM43Ð member PETA-3 (CDlsl) in normal human tissues: comparison
with CD9, CD63 and üsÞr integrin. J Histochem Cytochem. 45' 575.
75
Slupsky, J.R., Seehafer, J.G., Tang, S.C. (1989). Evidence that monoclonal antibodies
ugui"riôo9 antigen induce specifiõ association between CD9 and the platelet gþoprotein
trb/IIIa complex. J Biol Chem. 264' 12289'
Smeland, E.8., Fr¡nderud, S., Kvalheim, G., et aL. (1992). Isolation and characterisation of
human hematopoietic progenitor cells: An effective method for positive selection of CD34*
cells. Leukemia 6,845.
Spangrude, G.J., Heimfield, S.,'Weissman, I.L. (1988). Purification and characterisation of
mouse hematopoietic stem cells. Science 241' 58'
Stauss, L., Rowley, S., La Russa S., et al. (1936). Antigenic anal;sis of lematopoiesis'
V. Claracterisation of MY-10 antigen expression by normal lymphohematopoietic
progenitor e'ells. Exp Hematol. 14,878-
Sugalrar4 H.Y., Kanakr¡ra, T., Hashimoto, Y., et aI- (1994). Induction of programmed cell
death in human hematopoietíc cell lines by fibronectin via its interaction with very late
antigen 5.J E cp Med. 179,1757.
Sutherlan4 H.J., Eaves, C.J., Eaves, C. (1989). Characterisation and partiat purification of
human ma11ow cells capable of initiating long-term hematopoiesis ir¿ vitro- Blood74,1563'
Tanak4 R., Koike, K., Imai, T., et al. (lgg2). Stem cell factor enhances proliferation' but
not maturation of mu¡ine megakaryocytic progenitors in serum-free culture' Blood 80'
1743.
Tao, H., Gaudry, L., Rice, 4., et 41. (1999). Cord blood is better than bone marrow for
generating megakaryocytic progenitor cells. Exp Hemat ol - 27, 293
Tavassoli, M., Aoki, M. (1939). Localisation of megakaryocytes in the manow. Blood
Cells 15,3.
Tavassoli, M., Crosþ, W.H. (1963). Transplantation of manow to extamedullary sites'
Science 161,54.
Teixido, J.M.E., Sanders, I.C.M., Slaper-Cotenbach, M'C., et aL (1992)' Role of p1 and 
p2
integrins in the adhesion of human CD34* cells to fibronectin in an activation-dependent
way. Blood8l,344.
Testa, U., Pelosi, E., Gabbianelli, M., et al. (1993). Cascade transactivation of growth
factor receptors in early human hematopoiesis. Blood 81, 1442.
Till, J.8., McCulloch, E.A. (1961). A direct measurement of the radiation sensitivity of
normal bone ma¡row cells. Radiat Res- 74,213'
76
Toothill, V.J., Van Mourik, J.4., Nieuwenhuis, H.K., et al. (1990). Characterisation of the
enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J
Immunol. 145,283.
Trischmann, T.M., Schepers, K.G., Civin, C.I. (1993). Measurement of CD34* cells in
bone marrow by flow cytomeüy. J Hematother' 2,305
Tsai, S., Patel, V., Beaurnont, E. (1987). Differential binding of erythroid and myeloid
progenitors to fibroblasts and fibronectin. Blood 69' 1587 '
Tsuji, K., Lymar¡ S.D., Sudo, T., et al. (lgg2). Enhancement of murine hematopoiesis by
synérgistic interactions between steel factor (ligand for c-kit), interleukin-ll, and other
early acting factors in culture. Blood79,2855'
Vainchenker, W., Bouget, J., Guichard, J., et al- (L979). Megakaryocyte colony fomting
from human bone ma¡row precwsots. Blood 54,940'
verfaillie, c., Blakolmer, K., McGlave, P. (1990). Purified primitive human hematopoietic
progenitoi r"¡, *itlr long-term in vitro repopulæing ability adhere selectively to irradiated
bone ma¡row stroma. J Exp Med. I72,509.
Verfaillie, C.M. (1993). Soluble facto(s) produced by human bonc marrow stroma
increase cytokine-induced proliferatiott *d maturation of primitive hematopoietic
progenitors while preventing their terminal differentiation. Blood 82, 2045.
Verfaillie, C.M., Catanzano, P.M., Li, W. (lgg4). Macrophage inflammatory protein24
interleukin 3 and diffiisible mruïow stromal factors maintain human hematopoietic stem
cells for at least eight weeks in vitro. J Exp Med' 179,643'
Verfaillie, C.M., Hurley, R., Bhatia' C., et at. (1992). Role of bone marrow matix in
normal and abnormal hematopoiesis. Crit Rev Oncl Hematol. 16,201-
Villet-Gaugler, M.H., Breton-Gorius, J., Vainchenker, W' (1991)' Loss of attachment to
fibronectin with terminal human erytt[oid differentiation Blood 7 5, 865.
Vinci, G., Tabilo, 4., Deschamps, J.F., et al. (1984). Immunological study of in vitro
maturation of human megakaryocytes. Brit J Haematol. 56,589.
vischer, u.M., 'wagner, D. D. (1993). CD63 is a component of weibel-Palade bodies of
human endothelial cells. Blood 82,1184.
Visser, W.H., Bauman, J.G.J., Mulder,4.H., et al. (1984)' Isolation of murine pluripotent
stem cells. J Exp Med. 59,1576.
77
vormoor, J., Lapidot, T., Pflumio, F., et al. (1994). Immature human cord blood
p.og.nit*, á"grcft and proliferate to high levels in severe combined immunodeficient
mice. 81ood83,2489.
waldburger, K.E., Leonard, J.P., Quinto, c.M., et al. (1994). Stimulation of
-.grt"tí"cytopoiesis following in vivo adminisûation 
of recombinant murine interleukin-
12. Exp Hematol.22(suPPl), 497a'
Wayner, E.4., Carter, w.G., Piotrowics, R.S. (1988). The function of multiple
extracellular matrix recáptors in modening celr adhesion to extraceilular 
matrix: preparation
of monoclonal antibodi., to th. fibronectñr receptor that specificatly inhibit cell 
adhesion to
fibronectin and react with platelet gþoproteins Ic-tra. J Cell Biol' 107 ,1881'
wa¡mer, E.4., Garcia-Pardo, 4., Humphries, M.J., et al. (19S9). Identification and
characterisation of the lymphocyte adhésion receptor for an alternative cell attachment
domain in plasma fibronectin. J Cell BioL 109,321'
weiss, L. (1976). The hematopoietic microenvironment of the bone marrow' An
ultasructural study of the stroma in rats. anat Rec.l86, 161.
Wending, F., Marakovsþ, E., Debili, N., et al. (1994). C-Mpl ligand is a humoral 
regulator
of megakaryocytopoiesis . Nature 369, 57 l'
whitlock, c.4., Witte, o.N. (19s2). Long-term culture of B lymphocytes and their
precursors from mt¡ine bone marrow. Proc Natl Acad Sci. 79,3608'
v/illiams, D.4., Rios, M., stephens, c., et al. (1991). Fibronectin and vLA-4 in
hematopoietic stem cell-microenvironment interaction . Nature 3 52' 438'
Williams, D. (1993). Ex vivo expansion of hematopoietic stem and progenitor cells-
robbing Peter to pay Paul. Blood 81, 3169'
v/illiams, N., Eger, R.R., Jackson, H.M. (1982). Two factor requirements for murine
megakaryocyte colony formation. J Cell Physiol' 110, 101'
williams, N., Gill, K., Yasmeen, D. (1985). Murine megakaryocyte colony stimulating
factor: its relationship to IL-3. Leuk Res' 9,1487 '
wolf, N.s., Trentin, J.J. (1963). Hematopoietic colony studies v. Effect of hematopoietic
organ stroma on difêrentiationof pturipotent stem cells. J Exp Med' 127,205'
wolf, N.S. (1979). The hematopoietic microenvironment - clin Haematol' 8' 469'
The ins and outs of the transmembrane '4Wright, M.D., Tomlinson, M.G- (1994)
superfamily. Immunol Todøy 15, 588.
78
wunder, E., Sovalat, H., Hennor¡ R. (199Ð. Hand Book, Hematopoietic stem cells'
AtphaMed press, +tóO South Kettering Boulevard, Dayton, Ohio, 45439'2092U5A' 
126'
234.
Xu, D.D., Willaims, D.A. (1994). Interleukin 11: A multifunctional growth factor 
derived
from the microenvironment. Blood 83, 2023'
Yanai, N., sekine, c., Yagit4 H., et al. (lgg4). Role-for integrin very late activation
antigen-4 in stroma dependent erythropoie sis. Blood 83' 2844.
Yoder, M.C., Williams D.A. (1995). Matrix molecule interactions with hematopoietic 
stem
cells. Exp Hemstol. 23, 961 -
zar$an,E.D., Pallavicini, M.G., Ascensao, J.L., et al. (1992). Engraffnrent and 
long-term
"*prrrrío' 
of human fetá hemæopoietic stem cells in sheep following tansplantation in
vitro. J Clin Invest.89, 1178.
Zsebo,K. M., V/ypyctU J., McNiece, I. K., et al. (1990). Identification, purification 
and
biological charactårization of hematopoietic stem cell factor from buffalo fat liver-
conditioned medium. Cell 63,195-
Zuckerman, K.S., wicha, M.s. (1933). Exüacellular matrix production by the adherent
cells in long-terrr murine bone marrow cultures. Blood 61,540.
t 
(,,(
\'"\'
79
